Global Clean Energy (GCEH) 10-K/A 7 Oct 20 2019 FY Annual report (amended) Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2019	Sep. 10, 2020	Jun. 30, 2019
Document and Entity Information:
Entity Registrant Name	Global Clean Energy Holdings, Inc.
Document Type	10-K/A
Document Period End Date	Dec. 31, 2019
Amendment Flag	true
Amendment Description	The purpose of this Amendment No. 1 on Form 10–K/A to Global Clean Energy Holdings, Inc.’s annual report on Form 10–K for the fiscal years ended December 31, 2016, 2017, 2018, and 2019, filed with the Securities and Exchange Commission on October 6, 2020 (the “Form 10–K”), is solely to furnish Exhibit 101 to the Form 10–K in accordance with Rule 405 of Regulation S–T.
Entity Central Index Key	0000748790
Current Fiscal Year End Date	--12-31
Entity Common Stock, Shares Outstanding		358,499,606
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	FY
Entity Public Float			$ 19,269,000
Entity Interactive Data Current	Yes
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity File Number	0-12627
Is Entity Incorporation State Country Code	DE

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
CURRENT ASSETS
Cash and cash equivalents	$ 457,331	$ 5,226,489	$ 3,733	$ 22,164	$ 34,704
Accounts receivable			19,082	112,254	10,160
Inventory	22,942	22,941	22,942	22,942	26,544
Other current assets					36,846
Current asset, of discontinued operations					218,015
Total Current Assets	480,273	5,249,430	45,757	157,360	326,269
PROPERTY AND EQUIPMENT, NET		1,706	1,706	2,170	7,868
RIGHT-OF-USE ASSET	82,450
INTANGIBLE ASSETS, NET	2,501,592	2,746,818	2,992,045	3,237,272	3,482,498
DEBT ISSUANCE COSTS	500,000
PRE-ACQUISITION COSTS	2,588,441
DEPOSITS	3,253,253	5,253	5,253
OTHER NONCURRENT ASSETS				5,254	2,626
TOTAL ASSETS	9,406,009	8,003,207	3,044,761	3,402,056	3,819,261
CURRENT LIABILITIES
Accounts payable and accrued expenses	1,778,434	3,057,500	2,880,915	2,805,689	3,041,612
Accrued compensation and related liabilities	2,055,167	1,469,121	2,006,031	1,598,254	1,380,155
Accrued interest	1,734,527	1,372,413	1,049,888	737,774	455,029
Lease liabilities	82,882
Notes payable	1,369,856	1,369,856	1,369,856	1,369,856	1,369,856
Convertible notes payable	1,697,000	697,000	697,000	697,000	697,000
Derivative Liability	24,767,000	11,917,000			106,000
Total Current Liabilities	33,484,866	19,882,890	8,003,690	7,208,573	7,049,652
LONG-TERM LIABILITIES
Convertible notes payable		1,000,000
TOTAL LIABILITIES	33,484,866	20,882,890	8,003,690	7,208,573	7,049,652
STOCKHOLDERS' DEFICIT
Preferred stock - $0.001 par value; 50,000,000 shares authorized Series B, convertible; 13,000 shares issued and outstanding (aggregate liquidation preference of $1,300,000)	13	13	13	13	13
Common stock, $0.001 par value; 500,000,000 shares authorized; 344,029,434, 341,529,434, 341,529,434, 341,529,434, and 341,529,434 shares issued and outstanding, respectively	344,029	341,529	341,529	341,529	341,529
Additional paid-in capital	31,259,365	30,669,220	30,599,931	30,564,371	30,533,060
Accumulated deficit	(55,682,264)	(43,890,445)	(35,900,402)	(34,712,430)	(34,210,969)
Accumulated other comprehensive loss					105,976
Total Stockholders' Deficit	(24,078,857)	(12,879,683)	(4,958,929)	(3,806,517)	(3,230,391)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 9,406,009	$ 8,003,207	$ 3,044,761	$ 3,402,056	$ 3,819,261

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Statement of Financial Position [Abstract]
Preferred Stock, par or stated value	$ 0.001	$ 0.001	$ 0.001	$ 0.001	$ 0.001
Preferred Stock, shares authorized	50,000,000	50,000,000	50,000,000	50,000,000	50,000,000
Preferred Stock, shares issued	13,000	13,000	13,000	13,000	13,000
Preferred Stock, shares outstanding	13,000	13,000	13,000	13,000	13,000
Preferred Stock, liquidation preference	$ 1,300,000	$ 1,300,000	$ 1,300,000	$ 1,300,000	$ 1,300,000
Common Stock, par or stated value	$ 0.001	$ 0.001	$ 0.001	$ 0.001	$ 0.001
Common Stock, shares authorized	500,000,000	500,000,000	500,000,000	500,000,000	500,000,000
Common Stock, shares issued	344,029,434	341,529,434	341,529,434	341,529,434	341,529,434
Common Stock, shares outstanding	344,029,434	341,529,434	341,529,434	341,529,434	341,529,434

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended												6 Months Ended				9 Months Ended				12 Months Ended
	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Income Statement [Abstract]
Revenue							$ 179,288	$ 109,539	$ 50,334	$ 117,087	$ 79,583	$ 121,647			$ 159,873	$ 201,230			$ 339,161	$ 318,317			$ 369,702	$ 656,500	$ 537,807
Operating Expenses
General and administrative	126,509	937,765	1,027,577	127,591	135,178	126,664	289,158	179,566	216,869	150,299	401,838	454,060	1,065,342	261,842	396,434	855,898	2,091,851	389,433	685,592	1,006,197	3,061,580	1,282,037	1,012,614	1,587,966	1,707,496
Amortization of intangible assets	61,307	61,306	61,307	61,307	61,306	61,307	61,307	61,306	61,307				122,613	122,613	122,613		183,920	183,920	183,920		245,226	245,226	245,226
Prelliminary stage acquisition costs	106,381	82,693	934,243										1,016,936				1,123,317				1,625,834	529,454
Other Operating																								3,825	438,367
Total Operating Expenses	294,197	1,081,764	2,023,127	188,898	196,484	187,971	350,465	240,872	278,176	150,299	401,838		3,104,891	384,455	519,047	855,899	3,399,088	573,353	869,512	1,006,197	4,932,640	2,056,717	1,257,840	1,591,791	2,145,863
Operating Loss	(294,197)	(1,081,764)	(2,023,127)	(188,898)	(196,484)	(187,971)	(171,177)	(131,333)	(227,842)	(33,212)	(322,255)	454,060	(3,104,891)	(384,455)	(359,174)	(654,668)	(3,399,088)	(573,353)	(530,351)	(687,880)	(4,932,640)	(2,056,717)	(888,138)	(935,291)	(1,608,056)
Other Income (Expenses)
Other Income (Expenses), Net						425,000		28,279		3,635	67,349			425,000	28,279	54,528		425,000	28,279	58,163		425,000	12,279	72,704	10
Interest expense, net	(89,401)	(89,546)	(90,529)	(80,631)	(80,632)	(80,631)	(41,976)	(152,553)	(77,302)	(14,152)	(138,770)	(73,517)	(180,075)	(161,263)	(229,856)	(212,287)	(269,476)	(241,894)	(271,832)	(226,439)	(439,479)	(441,326)	(312,113)	(283,049)	(334,618)
Gain on settlement of liabilities											255,752					255,752				255,752	2,430,300			537,612	376,157
Change in fair value derivative and finance charges related to derivative liability													(2,619,000)								(8,850,000)	(5,917,000)
Change in fair value of derivative	(406,000)	(1,318,000)	3,397,000			344,369					(106,000)		2,619,000			(106,000)	2,213,000			(106,000)					(6,500)
Foreign currency transaction gain (loss)											106,563					105,563				106,563				106,563	(405)
Other Income (Expense), Net	316,599	1,228,454	(4,027,529)	(80,631)	(80,632)		(41,976)	(124,274)	(77,302)	(10,517)	572,753	(86,337)	(2,799,075)	263,737	(201,577)	486,416	(2,482,476)	(183,106)	(243,553)	475,899	(6,859,179)	(5,933,326)	(299,834)	433,830	34,644
LOSS FROM CONTINUING OPERATIONS										(43,729)	250,498													(501,461)	(1,573,412)
LOSS FROM DISCONTINUED OPERATIONS																									(7,444,940)
NET LOSS	$ 22,402	$ 146,690	$ (6,050,656)	$ (269,529)	$ (277,116)	$ 156,398	$ (213,153)	$ (255,607)	$ (305,144)	$ (43,729)	$ 250,498	$ (418,750)	$ (5,903,966)	$ (120,718)	$ (560,751)	$ (168,252)	$ (5,881,564)	$ (390,247)	$ (773,904)	$ (211,981)	$ (11,791,819)	$ (7,990,043)	$ (1,187,972)	$ (501,461)	$ (9,018,352)
BASIC AND DILUTED LOSS PER COMMON SHARE:
Net Loss per Common Share	$ 0	$ 0	$ (0.02)	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0		$ (0.02)	$ 0	$ 0	$ 0	$ (0.02)	$ 0	$ 0	$ 0	$ (0.03)	$ (0.02)	$ 0	$ 0	$ 0
BASIC AND DILUTED WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING	341,529,434	341,546,009	341,529,434	341,529,434	341,529,434	341,529,434	341,529,434	341,529,434	341,529,434	341,529,454	341,529,434		341,546,009	341,529,434	341,529,434	341,149,556	342,208,921	341,529,434	341,529,434	341,529,454	342,789,708	341,529,434	341,529,434	341,529,434	341,529,434

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Income Statement [Abstract]
Net Loss	$ (11,791,819)	$ (7,990,043)	$ (1,187,972)	$ (501,461)	$ (9,018,352)
Foreign currency translation adjustment					(1,150,651)
Reclassification accumulated foreign currency translation included in earnings				(105,976)
Comprehensive Income (Loss)	(11,791,819)	(7,990,043)	(1,187,972)	(607,437)	(10,169,003)
Add: net loss attributable to noncontrolling interest					7,444,940
Add: other comprehensive income loss attributable to controlling interest					(2,368,241)
Comprehensive Income (Loss) Attributable to Global Clean Energy Holdings, Inc.	$ (11,791,819)	$ (7,990,043)	$ (1,187,972)	$ (607,437)	$ (5,092,304)

CONSOLIDATED STATEMENTS OF CHAN

CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (DEFICIT) - USD ($)	Series B Convertible Preferred StockPreferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income	Noncontrolling Interest [Member]	Total
Beginning Balance at Dec. 31, 2014	$ 13	$ 339,311	$ 25,657,053	$ (28,946,103)	$ (66,586)	$ (5,204,123)	$ (8,220,435)
Beginning Balance, Shares at Dec. 31, 2014	13,000	339,311,434
Contributions from noncontrolling interests						429,743	429,743
Distribution to noncontrolling interests						(250,000)	(250,000)
Issuance of common stock for services, Value		$ 2,218	8,872				11,090
Issuance of common stock for services, Shares		2,218,000
Share-based compensation from issuance of options and compensation-based warrants			133,172				133,172
Accrual of preferential return for the noncontrolling interests						(2,039,224)	(2,039,224)
Write off of accrued interest and preferred return forgiven by partner			4,733,963			12,140,304	16,874,267
Foreign currency translation loss				(3,691,454)	172,562	2,368,240	(405)
Reclassification accumulated foreign currency translation included in earnings
Net Loss				(1,573,412)		(7,444,940)	(9,018,352)
Ending Balance at Dec. 31, 2015	$ 13	$ 341,529	30,533,060	(34,210,969)	105,976		$ (3,230,391)
Ending Balance, Shares at Dec. 31, 2015	13,000	341,529,434
Exercise of stock options, Shares
Share-based compensation from issuance of options and compensation-based warrants			31,311				$ 31,311
Foreign currency translation loss							106,563
Reclassification accumulated foreign currency translation included in earnings					(105,976)		(105,976)
Net Loss				(501,461)			(501,461)
Ending Balance at Dec. 31, 2016	$ 13	$ 341,529	30,564,371	(34,712,430)			$ (3,806,517)
Ending Balance, Shares at Dec. 31, 2016	13,000	341,529,434
Exercise of stock options, Shares
Share-based compensation from issuance of options and compensation-based warrants			35,560				$ 35,560
Reclassification accumulated foreign currency translation included in earnings
Net Loss				(1,187,972)			(1,187,972)
Ending Balance at Dec. 31, 2017	$ 13	$ 341,529	30,599,931	(35,900,402)			$ (4,958,929)
Ending Balance, Shares at Dec. 31, 2017	13,000	341,529,434
Exercise of stock options, Shares
Share-based compensation from issuance of options and compensation-based warrants			69,289				$ 69,289
Reclassification accumulated foreign currency translation included in earnings
Net Loss				(7,990,043)			(7,990,043)
Ending Balance at Dec. 31, 2018	$ 13	$ 341,529	30,669,220	(43,890,445)			(12,879,683)
Ending Balance, Shares at Dec. 31, 2018	13,000	341,529,434
Exercise of stock options		$ 2,500	12,500				$ 15,000
Exercise of stock options, Shares		2,500,000					2,500,000
Share-based compensation from issuance of options and compensation-based warrants			577,645				$ 577,645
Reclassification accumulated foreign currency translation included in earnings
Net Loss				(11,791,819)			(11,791,819)
Ending Balance at Dec. 31, 2019	$ 13	$ 344,029	$ 31,259,365	$ (55,682,264)			$ (24,078,857)
Ending Balance, Shares at Dec. 31, 2019	13,000	344,029,434

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Operating Activities
Net Loss	$ (11,791,819)	$ (7,990,043)	$ (1,187,972)	$ (501,461)	$ (9,018,352)
Net loss from discontinued operations					(7,444,940)
Net loss from continuing operations				(501,461)	(1,573,412)
Adjustments to reconcile net loss to net cash used in operating activities:
Foreign currency transaction gain				(105,976)
Gain on settlement of liabilities	(2,430,300)			(537,612)	(376,157)
Share-based compensation	577,645	69,289	35,560	31,311	133,172
Write down of long lived assets					438,320
Depreciation and amortization	246,932	245,227	245,691	250,924	312,085
Change in fair value of derivative liability	8,850,000	5,917,000
Changes in operating assets and liabilities:
Accounts receivable		19,083	93,172	(102,094)	1,012,977
Inventory				3,602	1,239
Other current assets				36,846	(15,665)
Accounts payable and accrued expenses	1,151,234	176,585	75,227	45,937	341,741
Accrued compensation and related liabilities	586,046	463,090	407,777	473,851
Interest payable	362,114	322,525	312,114	282,745
Other Operating Activities	431
Other noncurrent assets				(5,254)	5,760
Net Cash Used in Operating Activities, continued operations	(2,447,717)	(777,244)	(18,431)	(233,181)	280,088
Investing Activities
Pre-acquisition costs and deposit on refinery acquisition	(5,836,441)
Net Cash Used in Investing Activities, continued operations	(5,836,441)
Financing Activities
Proceeds received from derivative forward contract	4,000,000	6,000,000
Proceeds received from exercise of stock options	15,000
Debt issuance costs	(500,000)
Net Cash Provided by Financing Activities, continued operations	3,515,000	6,000,000
Cash Flows of discontinued operations:
Operating cash flows				220,641	(1,910,841)
Investing cash flows					6,416,913
Financing cash flows (including cash at year end)					(4,907,060)
Net Cash flows from discontinued operations				220,641	(400,988)
Net Cash Used in Operating Activities	(2,447,717)	(777,244)	(18,431)	(12,540)	(1,630,753)
Net Cash Used in Investing Activities	(5,836,441)				6,416,913
Net Cash Provided by Financing Activities	3,515,000	6,000,000			(4,907,060)
Effect of exchange rate changes on cash					(35,940)
Net change in Cash and Cash Equivalents	(4,769,158)	5,222,756	(18,431)	(12,540)	(156,840)
Cash and Cash Equivalents at Beginning of Period	5,226,489	3,733	22,164	34,704	191,544
Cash and Cash Equivalents at End of Period	457,331	5,226,489	3,733	22,164	34,704
Supplemental Disclosures of Cash Flow Information
Cash Paid for Interest
Cash Paid for Income Tax

ORGANIZATION AND SIGNIFICANT AC

ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES	NOTE A — ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES Description of Business Global Clean Energy Holdings, Inc., a Delaware corporation, and its wholly owned subsidiaries (collectively, the “Company”) is a U.S.-based integrated agricultural-energy biofuels company, and together with its subsidiaries holds assets across feedstocks and plant genetics, agronomics, cultivation, and regulatory approvals, commercialization, and downstream biorefining and storage. The Company is focused on the development and refining of non-food based bio-feedstocks and has a proprietary investment in Camelina sativa (“Camelina”), a fast growing, low input and ultra-low carbon intensity crop used as a feedstock for renewable fuels. In 2018 and 2019 the Company pursued the acquisition of a crude oil refinery in Bakersfield, California with the objective of retrofitting it to produce renewable diesel from Camelina and other non-food feedstocks. Subsequent to year end 2019, the Company completed the acquisition of the targeted refinery. The retrofitting of the refinery is expected to be completed in the first quarter of 2022. The Company has entered into a product offtake agreement with a major oil company for the majority of the renewable diesel that it will produce. See Note B which describes the agreement in more detail. Basis of Presentation The accompanying consolidated financial statements include the accounts of Global Clean Energy Holdings, Inc., and its wholly owned subsidiaries, and have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”). Intercompany accounts and transactions have been eliminated. In the opinion of the Company’s management, the consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. Cash and Cash Equivalents; Concentration of Credit Risk For purposes of the statement of cash flows, the Company had no cash and cash equivalents in excess of federally-insured limits. The Company considers all highly liquid debt instruments maturing in three months or less to be cash equivalents. The Company has maintained its cash balances at what management considers to be high credit-quality financial institutions. Accounts and Other Receivables Trade receivables are recorded at net realizable value. The allowance for doubtful accounts reflects the Company’s best estimate of probable losses inherent in the accounts receivable balance. The Company determines the allowance based on known troubled accounts, historical experience, and other currently available evidence. The Company reviews its allowance for doubtful accounts quarterly. Past due balances over 90 days and over a specified amount are reviewed individually for collectability. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. Property and Equipment Property and equipment are stated at cost. Depreciation of office equipment is computed using the straight-line method over estimated useful lives of 3 to 5 years. Field equipment is depreciated using the straight-line method over estimated useful lives of 5 to 15 years. Normal maintenance and repair items are charged to operating costs and are expensed as incurred. The cost and accumulated depreciation of property and equipment sold or otherwise retired are removed from the accounts and gain or loss on disposition is reflected in results of operations. Long-Lived Assets In accordance with U.S. GAAP the carrying values of intangible assets and other long-lived assets are reviewed on a regular basis for the existence of facts or circumstances that may suggest impairment. The Company recognizes impairment when the aggregate of the expected undiscounted future cash flows is less than the carrying amount of the asset. Impairment losses, if any, are measured as the excess of the carrying amount of the asset over its estimated fair value. Pre-Acquisition Costs The Company capitalizes its pre-acquisition costs once management determines that it is probable that the project will occur. Probability is determined based on i) management, having the requisite authority, has implicitly or explicitly authorized and committed to funding the acquisition or construction of a specific asset, ii) the financial resources are available consistent with such authorization, and iii) the ability exists to meet the necessary local and other governmental regulations. Cost capitalization occurs when the acquisition is probable. We capitalize those costs that are directly identifiable with the specific property and those costs that would be capitalized if the property were already acquired. We expense general and administrative and overhead costs and costs, including payroll, that would be considered support functions. In 2019, we capitalized $2.6 million of these costs which included financing costs, legal costs, pre-engineering costs and other contractual costs and expenses directly related to the purchase of the Bakersfield refinery in May 2020. In addition, we paid $3.2 million of deposits for the acquisition of the property. Debt Issuance Costs During 2018, we signed a letter of intent to acquire our Bakersfield Refinery. The acquisition of the refinery and the related $365 million of financing to retrofit it closed in May 2020. During 2019, we incurred $0.5 million of costs related to obtaining financing for the Bakersfield Refinery. These debt issuance costs have been deferred and recorded on the balance sheet and will be amortized over the term of the financing. See Note J in Subsequent Events for more detail on the financing. Derecognition of Liabilities The Company reviews its liabilities, including but not limited to, accounts payable, notes payable, accrued expenses, accrued liabilities and other legal obligations for a determination of the legal enforcement or settlement of an obligation. Upon conclusive evidence that an obligation may be extinguished, has expired, is discharged, cancelled or otherwise no longer legally exists, then the Company will derecognize the respective liability on its balance sheet. Income Taxes The Company utilizes the liability method of accounting for income taxes. Under the liability method, deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities and the carryforward of operating losses and tax credits, and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance against deferred tax assets is recorded when it is more likely than not that such tax benefits will not be realized. Assets and liabilities are established for uncertain tax positions taken or positions expected to be taken in income tax returns when such positions are judged to not meet the “more-likely-than-not” threshold based on the technical merits of the positions. Estimated interest and penalties related to uncertain tax positions are included as a component of general and administrative expense. Revenue Recognition On January 1, 2018, the Company adopted ASU 2014-09 Revenue from Contracts with Customers Prior to the adoption of ASC 606, the Company would recognize revenue when all of the following criteria were met: persuasive evidence of an arrangement exists; delivery occurred or services had been rendered; the seller's price to the buyer is fixed or determinable; collectability was reasonably assured; and title and the risks and rewards of ownership have transferred to the buyer. The Company’s revenues during 2015 – 2017 primarily consisted of contract advisory services, which included development and management services to other companies regarding their bio-fuels and/or feedstock development operations, on a fee for services basis. The advisory services revenue was recognized upon completion of the work in accordance with each advisory contract. Research and Development Research and development costs are charged to operating expenses when incurred. Fair Value Measurements and Fair Value of Financial Instruments The carrying amounts of the Company’s financial instruments that are not reported at fair value in the accompanying consolidated balance sheets, including cash and cash equivalents, accounts receivable, accounts payable, and accrued liabilities approximate their carrying value due to their short-term nature. The Company’s derivative liability related to its derivative forward contract is reported at fair value. U.S. GAAP specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company's market assumptions. These two types of inputs have created the following fair-value hierarchy: Level 1— Quoted prices for identical instruments in active markets. Level 2— Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and Level 3— Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. During October 2018, the Company entered into a derivative forward contract that also included a call option. This contract was used as a source of financing, and the Company received $6 million at the inception of the contract from the counterparty. The notional amount of the forward contract related to gallons of the commodity, Ultra Low Sulfur Diesel. Under the terms of the contract the Company was obligated to pay the equivalent of the notional amount multiplied by the market price of Ultra Low Sulfur Diesel at the settlement dates; however, the call option of the contract capped the market price of Ultra Low Sulfur Diesel. At the inception of the contract the fair value of the derivative liability exceeded the $6 million received by the Company, and as a result, the Company recognized a financing cost of $9.1 million. During October 2019, the derivative forward contract was amended, and the Company received an additional $4 million and the notional amount and liability increased accordingly. The derivative forward contract was amended again in April 2020. Under the amendment, the contract was replaced with a fixed payment obligation, whereby the Company agreed to pay the counterparty a total of $24.8 million, which included a payment of $4.5 million in June 2020, and six installment payments in 2022 totaling $20.3 million. The fair value of the derivative forward contract is primarily based upon the notional amount and the forward strip market prices of Ultra Low Sulfur Diesel, and is reduced by the fair value of the call option. The forward strip market prices are observable. However, to determine the fair value of the call option, Company used the Black’s 76 option pricing model. As a result, the contract as a whole is included in the Level 3 of the fair value hierarchy. The following presents changes in the derivative liability: Year Ended Quarter Ended 12/31/19 12/31/19 09/30/19 06/30/19 03/31/19 12/31/18 Beginning Balance $ 11,917,000 $ 14,130,000 $ 14,536,000 $ 15,854,000 $ 11,917,000 $ — New contract / contract additions 4,000,000 4,000,000 — — — 15,114,000 (Gain) loss in fair value recognized in earnings 8,850,000 6,637,000 (406,000 ) (1,318,000 ) 3,937,000 (3,197,000 ) $ 24,767,000 $ 24,767,000 $ 14,130,000 $ 14,536,000 $ 15,854,000 $ 11,917,000 During the quarter ended December 31, 2018, the Company recognized a charge in earnings of $5.9 million related to the derivative forward contract. This charge consisted of $9.1 million finance costs of the derivative, less a decrease in fair value of $3.2 million. Estimates Management uses estimates and assumptions in preparing financial statements. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and reported revenues and expenses. Significant estimates used in preparing these financial statements include a) those assumed in determining the valuation of common stock, warrants, and stock options, b) those assumed in determining the value of the derivative transactions, c) estimated useful lives of equipment and patent costs, and d) undiscounted future cash flows for purpose of evaluating possible impairment of long-term assets. It is at least reasonably possible that the significant estimates used will change within the next year. Income/Loss per Common Share Income/Loss per share amounts are computed by dividing income or loss applicable to the common stockholders of the Company by the weighted-average number of common shares outstanding during each period. Diluted income or loss per share amounts are computed assuming the issuance of common stock for potentially dilutive common stock equivalents. The number of dilutive warrants and options is computed using the treasury stock method, whereby the dilutive effect is reduced by the number of treasury shares the Company could purchase with the proceeds from exercises of warrants and options. The following instruments are currently antidilutive and have been excluded from the calculations of diluted income or loss per share at December 31, 2016, 2017, 2018 and 2019, as follows: December 31, 2019 2018 2017 2016 Convertible notes and accrued interest 98,794,390 93,657,637 26,156,533 24,266,533 Convertible preferred stock - Series B 11,818,181 11,818,181 11,818,181 11,818,181 Warrants — — — 3,083,332 Compensation-based stock options and warrants 199,027,315 137,427,315 52,586,692 84,782,003 Stock Based Compensation The Company recognizes compensation expenses for stock-based awards expected to vest on a straight-line basis over the requisite service period of the award based on their grant date fair value. However, in the case of awards with accelerated vesting, the amount of compensation expense recognized at any date will be based upon the portion of the award that is vested at that date. The Company estimates the fair value of stock options using a Black-Scholes option pricing model which requires management to make estimates for certain assumptions regarding risk-free interest rate, expected life of options, expected volatility of stock and expected dividend yield of stock. For the fiscal years ended December 31, 2019, 2018, 2017 and 2016, charges related to stock-based compensation amounted to approximately $577,645, $68,289, $33,560 and $33,311, respectively. For the fiscal years ended December 31, 2019, 2018, 2017 and 2016, all stock-based compensation is classified in general and administrative expense. Subsequent Events The Company has evaluated subsequent events through October 6, 2020, the date these consolidated financial statements were issued. See Note J to these consolidated financial statements for a description of events occurring subsequent to December 31, 2019. Recently Issued Accounting Statements Revenue Recognition In May 2014, the FASB issued Accounting Standards Update ("ASU") No. 2014-09, Revenue from Contracts with Customers Leasing Effective January 1, 2019 the Company adopted the Financial Accounting Standards Board's ("FASB") Accounting Standards Update No. 2016-02, Leases Stock Compensation In June 2018, the FASB issued ASU No. 2018-07 Improvements to Non-employee Share-based Payment Accounting Compensation - Stock Compensation Equity-Based Payments to Non-employees

BASIS OF PRESENTATION AND LIQUI

BASIS OF PRESENTATION AND LIQUIDITY	12 Months Ended
	Dec. 31, 2019
Notes to Financial Statements
BASIS OF PRESENTATION AND LIQUIDITY	NOTE B — BASIS OF PRESENTATION AND LIQUIDITY The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As shown in the accompanying consolidated financial statements, the Company incurred losses from continuing operations applicable to its common shareholders of $11.8 million, $8.0 million, $1.2 million, and $0.5 million, during the years ended December 31, 2019, 2018, 2017 and 2016, respectively, and has an accumulated deficit applicable to its common stockholders of $55.7 million, at December 31, 2019. The Company incurred operating losses of $4.9 million, $2.1 million, $0.9 million, and $0.9 million, during the years ended December 31, 2019, 2018, 2017 and 2016, respectively. At December 31, 2019, the Company had negative working capital of $33.0 million and a stockholders’ deficit applicable to its stockholders of $24.5 million. On May 4, 2020, a group of lenders agreed to provide a $300 million senior secured term loan facility to one of Global Clean Energy Holdings, Inc.’s subsidiaries to enable that subsidiary to acquire the equity interests of Bakersfield Renewable Fuels, LLC and to pay the costs of the retooling of the refinery owned by Bakersfield Renewable Fuels, LLC. Concurrently with the senior credit facility, a group of mezzanine lenders have agreed to provide a $65 million secured term loan facility to be used to pay the costs of repurposing and starting up the Bakersfield biorefinery. See, “Note J Subsequent Events.” In April of 2019, the Company executed a binding Product Offtake Agreement (the “Offtake Agreement”) with a major oil company (“Purchaser”) pursuant to which Purchaser has committed to purchase approximately 2.5 million barrels of renewable diesel annually from the Bakersfield Biorefinery, and the Company will be obligated to sell these quantities of renewable diesel to Purchaser. Purchaser’s obligation to purchase renewable diesel will last for a period of five years following the date that the Bakersfield Biorefinery commences operations. Purchaser has the option to extend the initial five-year term by an additional five years. Either party may terminate the Offtake Agreement if the Bakersfield Biorefinery does not meet certain production levels by certain milestone dates following the commencement of the Bakersfield Biorefinery’s operations.

PROPERTY AND EQUIPMENT

PROPERTY AND EQUIPMENT	12 Months Ended
	Dec. 31, 2019
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT	NOTE C – PROPERTY AND EQUIPMENT Property and equipment as of December 31, 2019, 2018, 2017, 2016 and 2015 are as follows: 2019 2018 2017 2016 2015 Field Equipment $ — $ 10,305 $ 10,305 $ 10,305 $ 10,574 Office Equipment 61,078 61,601 61,601 61,601 64,729 Total Cost 61,078 71,906 71,906 71,906 75,303 Less accumulated depreciation 61,078 70,200 70,200 69,736 67,435 Property and equipment, net $ — $ 1,706 $ 1,706 $ 2,170 $ 7,868 Depreciation expense for property and equipment was $0, $0, $464, $2,301 and $66,859 for the years ended December 31, 2019, 2018, 2017, 2016 and 2015 respectively.

PATENT LICENSE FEES

PATENT LICENSE FEES	12 Months Ended
	Dec. 31, 2019
Notes to Financial Statements
PATENT LICENSE FEES	NOTE D - PATENT LICENSE FEES Through a 2013 acquisition, the Company acquired certain patents, intellectual property and rights related to the development of Camelina as a biofuels feedstock, as a result of which it continues to incur costs related to patent license fees and patent applications for Camelina sativa plant improvements. These assets include three patents and the related intellectual property associated with these patents. These patents have an expected useful life of 17 years and are carried at cost less any accumulated amortization and any impairment losses. Amortization is calculated using the straight-line method over their remaining patent life. The termination of the patents are in 2029. Any future costs associated with the maintenance of these patents and patent and registration costs for any new patents that are essential to its business will be capitalized and amortized over the life of the patent once issued. The patent license assets as of the year ended December 31, 2019, 2018, 2017, 2016 and 2015 is shown in the following table: December 31 2019 2018 2017 2016 2015 Patent license fees $ 4,187,902 $ 4,186,289 $ 4,168,841 $ 4,168,841 $ 4,168,841 Less accumulated amortization (1,686,3107 ) (1,439,471 ) (1,176,796 ) (931,569 ) (686,343 ) Intangible Assets, Net $ 2,501,592 $ 2,746,818 $ 2,992,045 $ 3,237,272 $ 3,482,498 Amortization expense for intangible assets was approximately $245,000 for the years ended December 31, 2015, 2016, 2017, 2018 and 2019. The estimated amortization expense for the next five years is expected to be approximately $245,000 annually.

DEBT

DEBT	12 Months Ended
	Dec. 31, 2019
Disclosure Text Block [Abstract]
DEBT	NOTE E –DEBT Promissory Notes Prior to 2016 the Company invested in and purchased various assets and is carrying a note, that is due upon demand, related to such assets in the principal amount of $1.3 million and an interest rate of 18% per annum. Convertible Note Payable to Executive Officer On October 16, 2018, Richard Palmer, the Company’s Chief Executive Officer and President, entered into a new employment agreement with the Company and concurrently agreed to defer $1 million of his accrues salary and bonus for two years. In order to evidence the foregoing deferral, the Company and Mr. Palmer entered into a $1 million convertible promissory note (the “Convertible Note”). The Convertible Note accrued simple interest on the outstanding principal balance of the note at the annual rate of five percent (5%) and matures and becomes due and payable on October 15, 2020. The Company accrued interest expense on this note in 2018 and 2019 of $10,411 and $50,000 respectively. As of year end 2018 and 2019 the Company had recorded accrued interest payable of $10,411 and $60,411. Under the Convertible Note, Mr. Palmer has the right, exercisable at any time until the Convertible Note is fully paid, to convert all or any portion of the outstanding principal balance and accrued and unpaid interest into shares of Common Stock at an exercise price of $0.0154 per share. Convertible Notes Payable The Company has several notes that are convertible into the Company or the Company’s subsidiaries shares at different prices: from $0.03 per share into the parent company’s stock and up to $1.48 per share into a subsidiary’s common stock. These notes are past due their original maturity date and they continue to accrue interest at varying rates, from 8% to 10%. On a combined basis, as of December 31, 2019 the principal amount of these notes is $0.7 million. Settlement of Liabilities In 2019 the Company derecognized $2.4 million of previously outstanding liabilities upon concluding that these were no further legal obligations. In 2016, the Company derecognized $0.5 million of liabilities based upon analysis of its accounts payable aging. These amounts are included in gain on settlement of liabilities in the accompanying statement of operations.

STOCKHOLDERS' EQUITY

STOCKHOLDERS' EQUITY	12 Months Ended
	Dec. 31, 2019
Disclosure Text Block [Abstract]
STOCKHOLDERS' EQUITY	NOTE F— STOCKHOLDERS’ EQUITY Common Stock During 2016 through 2019, the Company issued a total of 2,500,000 shares of common stock related to the exercise of stock options. Series B Preferred Stock On November 6, 2007, the Company sold a total of 13,000 shares of Series B Convertible Preferred Stock (“Series B Shares”) to two investors for an aggregate purchase price of $1.3 million, less offering costs of $9,265. Each share of the Series B Shares has a stated value of $100. The Series B Shares may, at the option of each holder, be converted at any time or from time to time into shares of the Company’s common stock at the conversion price then in effect. The number of shares into which one Series B Share shall be convertible is determined by dividing $100 per share by the conversion price then in effect. The initial conversion price per share for the Series B Shares is $0.11, which is subject to adjustment for certain events, including stock splits, stock dividends, combinations, or other recapitalizations affecting the Series B Shares. Each holder of Series B Shares is entitled to the number of votes equal to the number of shares of the Company’s common stock into which the Series B Shares could be converted on the record date for such vote, and has voting rights and powers equal to the voting rights and powers of the holders of the Company’s common stock. No dividends are required to be paid to holders of the Series B shares. However, the Company may not declare, pay or set aside any dividends on shares of any class or series of the Company’s capital stock (other than dividends on shares of our common stock payable in shares of common stock) unless the holders of the Series B shares shall first receive, or simultaneously receive, an equal dividend on each outstanding share of Series B shares. In the event of any liquidation, dissolution or winding up of the Company, the holders of the Series B Preferred Stock shall be entitled to receive, prior to any distribution to the holders of the Common Stock, an amount equal to $100 per share, or $1,300,000 in the aggregate, plus an amount equal to any dividends declared and unpaid with respect to each such share.

STOCK OPTIONS AND WARRANTS

STOCK OPTIONS AND WARRANTS	12 Months Ended
	Dec. 31, 2019
Disclosure Text Block [Abstract]
STOCK OPTIONS AND WARRANTS	NOTE G – STOCK OPTIONS AND WARRANTS 2010 Stock Plan In 2010, the Company’s Board of Directors adopted the Global Clean Energy Holdings, Inc. 2010 Equity Incentive Plan (the “2010 Plan”) wherein 20,000,000 shares of the Company's common stock were reserved for issuance thereunder. Options and awards granted to new or existing officers, directors, employees, and non-employees vest ratably over a period as individually approved by the Board of Directors generally over four years, but not in all cases. The 2010 Plan provides for a three-month exercise period of vested options upon termination of service. The exercise price of options granted under the 2010 Plan is equal to the fair market value of the Company’s common stock on the date of grant. Options issued under the 2010 Plan have a maximum term of ten years for exercise and may be exercised with cash consideration or through a cashless exercise in which the holder forfeits a portion of the award in exchange for shares of common stock of the remaining portion of the award. As of December 31, 2019, there were no shares available for future option grants under the 2010 Plan. The 2010 Plan expired in April 2020 and was replaced with the 2020 Equity Incentive Plan. See Note J for additional information. The Company’s Board of Directors has granted stock options to certain officers, directors, employees, and non-employees, which options were not part of the 2010 Plan or any other formal equity incentive plan. During the fiscal years ended December 31, 2016, 2017, 2018 and 2019, the Company granted the following stock options under the 2010 Plan and outside of the 2010 Plan: 2016: On May 26, 2016, the Company granted employees and consultants a total of 2,300,000 incentive stock options and 1,000,000 non-qualified stock options respectively. These options vest 25% annually on the anniversary of the date of grant beginning on May 25, 2017 and each year thereafter until fully vested. The options expire five years from the date of grant and have an exercise price of $0.003. On July 1, 2016, the Company granted its Chairman of the Board a five-year non-qualified stock option to purchase 500,000 shares of Common Stock at an exercise price of $0.003. The options vest monthly over one year beginning on the grant date. On December 14, 2016, the Company granted employees and consultants a total of 3,000,000 incentive stock options and 500,000 non-qualified stock options respectively. These options vest quarterly over three years beginning on the grant date. The options expire five years from the date of grant and have an exercise price of $0.0017. 2017: On July 1, 2017, the Company granted its Chairman of the Board a five-year non-qualified stock option to purchase 500,000 shares of Common Stock at an exercise price of $0.015. The options vest monthly over one year beginning on the grant date. On November 1, 2017, the Company granted employees and consultants a total of 2,500,000 incentive stock options and 500,000 non-qualified stock options respectively. These options vest quarterly over three years beginning on the grant date. The options expire five years from the date of grant and have an exercise price of $0.0022. 2018: For legal services rendered, on January 29, 2018 the Company granted to one of its attorneys a fully vested, five-year, non-qualified stock option to purchase 750,000 shares of the Company’s common stock at an exercise price of $0.0056 per share. On July 1, 2018, the Company granted its Chairman of the Board a five-year non-qualified stock option to purchase 500,000 shares of Common Stock at an exercise price of $0.0056. The options vest monthly over one year beginning on the grant date. On September 17, 2018, the Company granted its Executive Vice President a five-year non-qualified stock option to purchase 5,000,000 shares of Common Stock at an exercise price of $0.035. The options vested immediately upon grant. On October 16, 2018, the Company granted its Chief Executive Officer a five-year non-qualified stock option to purchase 110 million shares of Common Stock at an exercise price of $0.0154, subject to the Company’s achievement of certain market capitalization goals. On December 14, 2018, the Company granted a non-qualified stock option to purchase up to 2,500,000 to a consultant. The option (i) has an exercise price of $0.007(equal to the closing market price on the date of the grant), (ii) has a five-year term, and (iii) was fully vested and immediately exercisable upon grant. 2019: On January 15, 2019, the Company granted its Executive Vice President a five-year non-qualified stock option to purchase 50 million shares of Common Stock at an exercise price of $0.02, subject to the Company’s achievement of certain market capitalization goals. On June 21, 2019 the Company entered into a Board Advisor Agreement with a prospective Board member (who subsequently became a member of the Board of Directors). As compensation for his services under the Board Advisor Agreement, the Board granted to this Director a non-qualified stock option to purchase up to 500,000 shares of the Company’s common stock, which option has an exercise price of $0.08 (based on the closing market price), a five year term, and the following vesting schedule: (i) Options to purchase 125,000 shares vested immediately as of the date grant, and (ii) options to purchase 125,000 additional shares vested on each of September 20, 2019, December 20, 2019 and March 20, 2020. The Board also granted to this prospective Director a second non-qualified stock option to purchase up to 500,000 shares of the Company’s common stock, which option has an exercise price of $0.08, a five year term, and would vest if/when this prospective Director joins the Board of Directors of the Company, provided that this prospective Director is appointed to the Board during the term of the Board Advisor Agreement. This appointment occurred in May 2020. On June 21, 2019 the Company granted its Executive Vice President a five-year non-qualified stock option to purchase 10,000,000 shares at an exercise price of $0.0165. The option vests at 25% at issuance and the balance over 36 months. On July 1, 2019, the Company granted its Chairman of the Board a five-year non-qualified stock option to purchase 500,000 shares of Common Stock at an exercise price of $0.065. The options vest monthly over one year beginning on the grant date. On July 5, 2019 the Company granted to a consultant a five-year non-qualified stock option to purchase 5,000,000 shares of Common Stock at an exercise price of $0.09. The option vesting is conditional upon the Company consummating its contemplated acquisition by March 31, 2020 and upon such acquisition will vest at one-third upon closing and one-third each on the first and second anniversary of closing. A summary of the option award activity and awards outstanding at December 31, 2019 is as follows: Shares Under Option Weighted Average Exercise Price Weighted Average Remaining Contractual Life Aggregate Intrinsic Value Outstanding at December 31, 2015 93,208,997 $ 0.015 2.2 years $ — Granted 7,300,000 0.002 Exercised — Forfeited (4,800,000 ) 0.024 — Expired (10,926,994 ) 0.008 — Outstanding at December 31, 2016 84,782,003 0.015 1.7 years   — Granted 3,500,000 0.004 Exercised — Forfeited (7,500,000 ) 0.006 — Expired (28,195,311 ) 0.018 — Outstanding at December 31, 2017 52,586,692 0.013 1.6 years   600 Granted 118,750,000 0.015 Exercised — Forfeited (24,959,377 ) 0.015 — Expired (8,950,000 ) 0.022 — Outstanding at December 31, 2018 137,427,315 0.014 4.4 years   28,260 Granted 66,500,000 0.019 Exercised (2,500,000 ) 0.006 Forfeited — — Expired (2,400,000 ) 0.010 — Outstanding at December 31, 2019 199,027,315 0.016 3.6 years   14,360,463 Vested and exercisable at December 31, 2019 184,964,315 $ 0.016 3.6 years $ 13,468,745 The fair value of stock option grants with only continued service conditions for vesting is estimated on the grant date using a Black-Scholes option pricing model. The Company estimates the fair value of stock options that have both service and market conditions on the grant date using a lattice model. The following table illustrates the assumptions used in estimating the fair value of options granted during the periods presented: For the Years Ended December 31, 2019 2018 2017 2016 Expected Term (in Years) 2 to 5 2 to 5 3 to 3.75 3.75 Volatility 123 % 123 % 175%-189% 142%-156% Risk Free Rate 2.8 % 2.8 % 1.9%-2.0% 1.4%-2.0% Dividend Yield 0 % 0 % 0 % 0 % Suboptimal Exercise Factor (1) 1.3 1.3 n/a n/a Exit Rate Pre-vesting (2) 0 % 0 % n/a n/a Exit Rate Post-vesting (3) 0 % 0 % n/a n/a Aggregate Grant Date Fair Value $ 326,644 $ 396,074 $ 12,737 $ 19,038 (1) The suboptimal exercise factor estimates the value realized by the holder upon exercise of the option and the estimated point at which an option holder would exercise an in-the-money option. The Company estimated the suboptimal factor based on the holder realizing a pre-tax profit of $500,000. Used for lattice model purposes only. (2) Assumed forfeiture rate for market condition option awards prior to vesting. Used for lattice model purposes only. (3) Assumed expiration or forfeiture rate for market condition option awards after vesting. Used for lattice model purposes only. During the years ended December 31, 2019 and 2018 the Company granted 110,000,000 and 50,000,000 options, respectively, to related parties that have both requisite service conditions and market conditions. The requisite service period for the market condition options granted during 2019 was three years and the options vest in three tranches: 28% of the award vests when the market cap exceeds $7 million for a thirty day period; 33% of the award vests when the market cap exceeds $15 million for a thirty day period; and 40% of the award vests when the market cap exceeds $25 million for a thirty day period. The requisite service period for the market condition options granted during 2018 was three years and the options vest in three tranches: 28% of the award vests when the market cap exceeds $7 million for a thirty day period; 36% of the award vests when the market cap exceeds $15 million for a thirty day period; and 36% of the award vests when the market cap exceeds $25 million for a thirty day period. As of May 31, 2019, all of the outstanding market condition awards issued during 2019 and 2018 were fully vested. For the years ended December 31, 2019, 2018, 2017, and 2016 the Company recognized stock compensation expenses related to stock option awards of $577,645; $69,289; $35,560; and $31,311; respectively. The Company recognizes all stock-based compensation in general and administrative expenses in the accompanying consolidated statements of operations. As of December 31, 2019, there was approximately $106,000 of unrecognized compensation cost related to option awards that will be recognized over the remaining service period of approximately 2.25 years. Stock Purchase Warrants The Company has, from time to time, previously issued warrants for the purchase of Common Stock. During the year ended December 31, 2016 all 3,083,332 previously outstanding fully vested stock warrants expired. As of December 31, 2019 there were no outstanding stock warrants. In 2020, the Company issued, to a party interested in Camelina development, a non-transferable warrant for approximately eight-percent interest in its subsidiary, Sustainable Oils, Inc. for approximately $20 million. The warrant expires on June 1, 2021.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Dec. 31, 2019
Income Tax Disclosure [Abstract]
INCOME TAXES	NOTE H— INCOME TAXES Income taxes are provided for temporary differences between financial and tax bases of assets and liabilities. The following is a reconciliation of the amount of benefit that would result from applying the federal statutory rate to pre-tax loss with the benefit from income taxes for the years ended December 31, 2015, 2016, 2017, 2018 and 2019: The components of deferred tax assets and liabilities are as follows at December 31, 2015, 2016, 2017, 2018 and 2019, using a combined deferred income tax rate of 40% for 2015 and 2016 and 28% for 2017, 2018 and 2019: The provisions for income taxes for the years ended December 31, 2019 and 2018 through 2016 are as follows: 2019 2018 2017 2016 2015 Current: Federal $ (265,000 ) $ (418,000 ) $ (127,000 ) $ 110,000 $ (319,000 ) State (123,000 ) (193,000 ) (36,000 ) 31,000 Deferred: Federal (1,992,000 ) (1,111,000 ) (241,000 ) 129,000 140,000 State (920,000 ) (513,000 ) (69,000 ) 37,000 Change in Valuation Allowance 3,300,000 2,235,000 473,000 (307,000 ) 179,000 Provision for income taxes $ — $ — $ — $ — $ — A reconciliation of the federal statutory tax rate to the effective tax rate is as follows: 2019 2018 2017 2016 2015 Federal statutory rate 21 % 21 % 21 % 34 % 34 % State, net of federal tax benefit 6.98 % 6.98 % 6.98 % 5.83 % 5.83 % Effect of permanent differences State return to provision Change in valuation allowance -28 % -28 % -28 % -40 % -40 % Effective tax rate — — — — — The company uses the asset-liability method of computing deferred taxes in accordance with FASB ASC Topic 740. The difference between the effective tax rate and the statutory tax rates is due primarily to the impact of the valuation allowance resulting in zero tax provision being recorded. Tax law changes enacted in 2018 reduced the statutory federal rate from 34% to 21%. The deferred tax asset has been reduced to reflect the newly enacted rate, and was equally offset by the change in valuation allowance. At December 31, 2019 and 2018 through 2015, the deferred income tax assets consisted of the following: 2019 2018 2017 2016 2015 Deferred tax assets: $ 14,563,000 $ 11,263,000 $ 9,028,000 $ 8,555,000 $ 8,862,000 Less: Valuation Allowance (14,563,000 ) (11,263,000 ) (9,028,000 ) (8,555,000 ) (8,862,000 ) Net deferred income taxes $ — $ — $ — $ — $ — Deferred income taxes arise from temporary differences between the tax basis of assets and liabilities and their reported amounts in the financial statements, which will result in taxable or deductible amounts in the future. The majority of the balance is due deferred compensation, share based payments, the fair value of derivatives, and to continued losses resulting in NOL carryforwards, which may not be realized in future periods. As such, the company has recorded a 100% valuation allowance against the deferred tax assets. At December 31, 2019 and 2018 through 2015, the deferred income tax assets consisted of the following temporary differences: 2019 2018 2017 2016 2015 Net operating losses $ 8,530,000 $ 8,140,000 $ 7,529,000 $ 7,366,000 $ 7,507,000 Share based compensation 269,000 107,000 87,000 73,000 483,000 Accrued payroll 1,631,000 1,359,000 1,412,000 1,116,000 830,000 Impairment — — — — 42,000 Derivative Liability 4,132,000 1,656,000 — — — Total deferred tax assets 14,562,000 11,262,000 9,028,000 8,555,000 8,862,000 Less: Valuation allowance (14,562,000 ) (11,262,000 ) (9,028,000 ) (8,555,000 ) (8,862,000 ) $ — $ — $ — $ — $ — At December 31, 2019 through 2015, the Company has federal net operating loss carryforwards of approximately: 2019 2018 2017 2016 2015 Net operating losses $ 21,152,000 $ 19,765,000 $ 17,579,000 $ 17,169,000 $ 17,523,343 Net operating losses begin to expire in the year ending 2021 through 2029. Inasmuch as it is not possible to determine when or if the net operating losses will be utilized, a valuation allowance has been established to offset the benefit of the utilization of the net operating losses. As of December 31, 2019, the Company had available net operating losses of approximately $21.2 million which can be utilized to offset future earnings of the Company. The utilization of the net operating losses is dependent upon the tax laws in effect at the time such losses can be utilized. The loss carryforwards expire between the years 2021 and 2037. Should the Company experience a significant change of ownership, the utilization of net operating losses could be reduced. The Company and its subsidiaries file tax returns in the U.S. Federal jurisdiction and, in the state of California. The Company is no longer subject to U.S. federal tax examinations for tax years before and including December 31, 2015. The Company is no longer subject to examination by state tax authorities for tax years before and including December 31, 2015. During the years ended December 31, 2016, 2017, 2018 and 2019, the Company did not recognize interest and penalties.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Dec. 31, 2019
Disclosure Text Block [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE I – COMMITMENTS AND CONTINGENCIES Employment Agreements President and Chief Executive Officer. Effective December 31, 2014, the Company entered into an employment agreement (the “2014 Employment Agreement”) with its President and Chief Executive Officer (“CEO”), for a term of five years. Under the Employment Agreement, we granted the CEO an incentive option to purchase up to 16,959,377 shares of Common Stock at an exercise price of $0.0041 (the closing trading price on the date the agreement was signed and approved), with 25% vesting immediately and the balance vesting in equal amounts over the next 48 months. Under the 2014 Employment Agreement, the CEO was entitled to receive a base salary of $250,000 and an annual bonus payment contingent on the CEO’s satisfaction of certain performance criteria. The target annual bonus amount was 50% of the CEO’s base salary, subject to the Board’s discretion to increase the amount of the bonus or adjust the performance criteria On October 16, 2018, the Company and the CEO entered into a new Executive Employment Agreement (the “2018 Employment Agreement”) that replaced the 2014 Employment Agreement. The 2018 Employment Agreement runs through October 15, 2023 and compensates the CEO at an annual base salary of $300,000 per year. Upon the closing of the acquisition of the Company's Bakersfield, California, refinery on May 7, 2020 the Company and the CEO amended the 2018 Employment Agreement to increase the CEO’s annual base salary to $350,000, effective immediately. Under the 2018 Employment Agreement, the CEO’s target annual bonus amount is 50% of the CEO’s base salary, subject to the Board’s discretion to increase the amount of the bonus or adjust the performance criteria. Under the 2018 Employment Agreement, the Company granted the CEO a five-year non-qualified stock option (“Option”) to purchase 110 million shares of Common Stock at an exercise price of $0.0154, subject to the Company’s achievement of certain market capitalization goals. Under the Option, Mr. Palmer vests, and can exercise the Option, with respect to 30,000,000 shares when the Company’s market capitalization first reaches $7 million, another 40,000,000 shares vest under the Option when the Company’s market capitalization reaches $15 million, and 40,000,000 shares vest when the Company’s market capitalization first reaches $25 million. The term “market capitalization” is defined in the 2018 Employment Agreement to mean the product of the number of shares of Common Stock issued and outstanding at the time market capitalization is calculated, multiplied by the average closing price of the Common Stock for the 30 consecutive trading days prior to the date of calculation as reported on the principal securities trading system on which the Common Stock is then listed for trading, including the OTC Pink marketplace, the NASDAQ Stock Market, or any other applicable stock exchange. Executive Vice President - Development & Regulatory Affairs (the “EVP”). Effective January 15, 2019, the Company entered into a three-year employment agreement with its EVP which agreement was amended on May 7, 2020. Under the employment agreement, the EVP is paid an annual base salary of $310,000 and is entitled to receive an annual bonus of up to 50% of his annual base salary if the EVP meets certain performance targets. Under the EVP’s employment agreement, the Company granted the EVP a five-year non-qualified stock option to purchase 50 million shares of Common Stock at an exercise price of $0.02, subject to the Company’s achievement of certain market capitalization goals. The foregoing option vest in three tranches when the Company’s market capitalization reached $7 million, $15 million, and $25 million. Leases On May 1, 2019, the Company amended its office lease to extend the lease term to July 31, 2022. Operating Year Ending Gross Less: Discount Lease December 31, Payments Discount Obligation 2020 $ 34,000 $ 5,000 $ 29,000 2021 35,000 3,000 32,000 2022 20,000 1,000 19,000 Total $ 89,000 $ 9,000 $ 80,000 Legal In the ordinary course of business, the Company may face various claims brought by third parties and the Company may, from time to time, make claims or take legal actions to assert the Company’s rights, including intellectual property rights, contractual disputes and other commercial disputes. Any of these claims could subject the Company to litigation. In the first quarter of 2018 we received $0.4 million as part of a settlement we entered into with the purchaser of our former Mexican biofuel farms. This settlement was in regards to the use of our intellectual property rights. In August 2020, a complaint was filed against GCE Holdings Acquisitions, LLC for a claimed breach of a certain consulting agreement. The claim is for $1.2 million. The Company is in the process of evaluating the merits of the claim and will determine a course of action in the near future. Management believes the outcomes of currently pending claims will not likely have a material effect on the Company’s consolidated financial position and results of operations. Indemnities and Guarantees In addition to the indemnification provisions contained in the Company's organization documents, the Company generally enters into separate indemnification agreements with the Company's directors and officers. These agreements require the Company, among other things, to indemnify the director or officer against specified expenses and liabilities, such as attorneys' fees, judgments, fines and settlements, paid by the individual in connection with any action, suit or proceeding arising out of the individual's status or service as the Company's directors or officers, other than liabilities arising from willful misconduct or conduct that is knowingly fraudulent or deliberately dishonest, and to advance expenses incurred by the individual in connection with any proceeding against the individual with respect to which the individual may be entitled to indemnification by the Company. The Company also indemnifies its lessor in connection with its facility lease for certain claims arising from the use of the facility. These guarantees and indemnities do not provide for any limitation of the maximum potential future payments the Company could be obligated to make. Historically, the Company has not been obligated nor incurred any payments for these obligations and, therefore, no liabilities have been recorded for these indemnities and guarantees in the accompanying consolidated balance sheets.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Dec. 31, 2019
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE J – SUBSEQUENT EVENTS On May 7, 2020 through BKRF OCB, LLC, one of the Company’s indirect subsidiaries, the Company purchased all of the outstanding equity interests of Bakersfield Renewable Fuels, LLC from Alon Paramount Holdings, Inc. (“Alon Paramount”) for $40,000,000. Bakersfield Renewable Fuels, LLC owns an oil refinery in Bakersfield, California that the Company is retooling into a biorefinery. In connection with the acquisition, BKRF OCB, LLC agreed to undertake certain cleanup activities at the refinery and provide a guarantee for liabilities arising from the cleanup. The Company has assumed significant environmental and clean-up liabilities associated with the purchase of the Bakersfield Refinery. Bakersfield Renewable Fuels, LLC, formerly Alon Bakersfield Property, Inc. is a party to an action pending in the United States Court of Appeals for the Ninth Circuit. In June 2019, the jury awarded the plaintiffs approximately $6.7 million against the Company and Paramount Petroleum Corporation (a parent company of Alon Bakersfield in 2019). Bakersfield Renewable Fuels has filed post-trial motions to alter or amend the judgment, or, in the alternative, for a new trial. Bakersfield Renewable Fuels is also assessing options for legal action. The hearing on this matter was heard in October of 2019, and the ruling is pending. Under the Share Purchase Agreement, Alon Paramount agreed to assume and be liable for (and to indemnify, defend, and save Bakersfield Renewable Fuels harmless from) this litigation. All legal fees in this matter are being paid by Paramount Petroleum Corporation. Concurrently with the closing of the acquisition, the Company entered into a Call Option Agreement with Alon Paramount pursuant to which the Company granted to Alon Paramount an option to purchase from Global Clean Energy Holdings, Inc. up to 33 1/3% of the membership interests of another subsidiary that indirectly owns Bakersfield Renewable Fuels, LLC based on the Company’s purchase price. The foregoing option can be exercised by Alon Paramount until the 90 th On May 4, 2020, in order to fund the purchase of Bakersfield Renewable Fuels, LLC, BKRF OCB, LLC entered into a senior secured credit agreement with a group of lenders (the "Senior Lenders") pursuant to which the Senior Lenders agreed to provide a $300 million senior secured term loan facility to BKRF OCB, and to pay the costs of the retooling the Bakersfield Biorefinery. The senior loan bears interest at the rate of 12.5% per annum, payable quarterly. The principal of the senior loans is due at maturity, provided that BKRF OCB, LLC must offer to prepay the senior loans with any proceeds of such asset dispositions, borrowings other than permitted borrowings, proceeds from losses, and excess net cash flow. BKRF OCB, LLC may also prepay the senior loan in whole or in part with the payment of a prepayment premium. As additional consideration for the senior loans, the Senior Lenders were issued Class B Units in BKRF HCP, LLC, an indirect parent company of BKRF OCB, LLC. The senior loans are secured by all of the assets of BKRF OCB, LLC (including its membership interests in Bakersfield Renewable Fuels, LLC), all of the outstanding membership interest in BKRF OCB, LLC, and all of the assets of Bakersfield Renewable Fuels, LLC. On May 4, 2020, BKRF HCB, LLC, the indirect parent of BKRF OCB, LLC, entered into a credit agreement with a group of mezzanine lenders who agreed to provide a $65 million secured term loan facility to be used to pay the costs of repurposing and starting up the Bakersfield biorefinery. As of September 30, 2020, BKRF HCB, LLC has not drawn down on the credit facility. The mezzanine loans bear interest at the rate of 15.0% per annum on amounts borrowed, payable quarterly, provided that the borrower may defer interest to the extent it does not have sufficient cash to pay the interest, such deferred interest being added to principal. As additional consideration for the mezzanine loans, the mezzanine lenders will be issued Class C Units in BKRF HCP, LLC at such times as advances are made under the mezzanine loans. The mezzanine loans will be secured by all of the assets of BKRF HCP, LLC, including all of the outstanding membership interest in BKRF FHCB, LLC. The mezzanine loans mature in November 2027. In December 2019, a novel strain of coronavirus diseases (“COVID-19”) was first reported in Wuhan, China. Less than four months later, on March 11, 2020, the World Health Organization declared COVID-19 a global pandemic. The extent of COVID-19’s effect on the Company’s operational and financial performance will depend on future developments, including the duration, spread and intensity of the pandemic, all of which are uncertain and difficult to predict considered the rapidly evolving landscape. The Company is currently analyzing the potential impacts to its business. At this time, it is not possible to determine the magnitude of the overall impact of COVID-19 on the Company. On April 30, 2020 GCE Acquisitions entered into an Engineering, Procurement and Construction Agreement with ARB, Inc. (“ARB”) pursuant to which ARB has agreed to provide services for the engineering, procurement, construction, start-up and testing of the Bakersfield Biorefinery. The agreement, which was assigned by GCE Acquisitions to BKRF Senior Borrower, provides for ARB to be paid on a cost-plus fee basis subject to a guaranteed maximum price of $201.4 million, subject to increase for approved change orders. On May 7, 2020, the Board of Directors of the Company amended the employment agreements of Richard Palmer, the Company’s Chief Executive Officer, and Noah Verleun, the Company’s Executive Vice President, to increase their annual base salaries to $350,000 and $310,000, respectively. On April 10, 2020, the Company’s Board of Directors adopted the 2020 Equity Incentive Plan (“2020 Plan”) pursuant to which the Board of Directors reserved an aggregate of 20,000,000 shares of Common Stock for future issuance. The 2020 Plan became effective on April 10, 2020. As of September 10, 2020, options for the purchase of 7,095,000 shares have been granted under the 2020 Plan to attract and retain the necessary personnel to meet the Company’s objectives. The 2020 Plan will expire on April 9, 2030, and no further awards may be granted after such date. The 2020 Plan provides for the following types of awards: incentive stock options, nonstatutory stock options, restricted stock awards, restricted stock unit awards, stock appreciation rights, performance stock awards, performance cash awards, and other stock-based awards. Stock awards may be granted under the 2020 Plan to employees (including officers) and consultants of the Company or affiliates, and to members of the Company’s Board of Directors. In 2020, the Company issued 5,542,857 shares, 7,677,315 shares and 750,000 shares upon exercises of outstanding options to an officer of the Company, a consultant to the company and an attorney who provided services to the Company (who is also a family member of the CEO), respectively.

QUARTERLY FINANCIAL DATA (Unaud

QUARTERLY FINANCIAL DATA (Unaudited)	12 Months Ended
	Dec. 31, 2019
Quarterly Financial Information Disclosure [Abstract]
QUARTERLY FINANCIAL DATA (Unaudited)	QUARTERLY FINANCIAL DATA ) As described in the “Explanatory Note” prior to Part I to this comprehensive Annual Report, the following unaudited quarterly periods for the three-months ending March 31, the three and six month periods ending June 30 and the three and nine month periods ending September 30 for each year 2019, 2018, 2017 and 2016, and the respective periods for comparative purposes are being filed herein and in lieu of the filing Quarterly Reports on Form 10-Q for 2019, 2018, 2017 and 2016. The quarterly information for 2015 was previously filed in three Forms 10-Q that were filed in 2015. The quarterly information in 2015 reflects the Mexico Jatropha operations that were discontinued in the fourth quarter of 2015. The following unaudited interim financial statements have been prepared pursuant to the rules and regulations of the SEC. The footnote disclosures normally included in financial statements prepared in accordance with United States generally accepted accounting principles (GAAP) have been omitted.. These unaudited statements reflect all adjustments, consisting of normal recurring adjustments, which in the opinion of management are necessary for fair presentation of the information contained therein. Interim results are not necessarily indicative of results for a full year. The following unaudited financial statements should be read in conjunction with the audited financial statements and notes thereto included above in this Annual Report for the year ended December 31, 2019. The accounting policies in preparation of interim reports are the same as those used for the above audited annual reports included in this Annual Report. CONSOLIDATED BALANCE SHEETS (Unaudited) As of March 31, 2019 2018 2017 ASSETS CURRENT ASSETS Cash and cash equivalents $ 4,166,517 $ 285,890 $ 63,244 Accounts receivable — 19,082 — Inventory 22,942 22,942 22,942 Total Current Assets 4,189,459 327,914 86,186 PROPERTY AND EQUIPMENT, NET 1,706 1,706 1,706 RIGHT-OF-USE ASSET 104,000 — — INTANGIBLE ASSETS, NET 2,685,512 2,930,738 3,175,965 DEBT ISSUANCE COSTS — — — PRE-ACQUISITION COSTS — — — DEPOSITS 5,253 5,253 5,253 TOTAL ASSETS $ 6,985,930 $ 3,265,611 $ 3,269,110 LIABILITIES AND STOCKHOLDERS’ DEFICIT CURRENT LIABILITIES Accounts payable and accrued expenses $ 3,916,364 $ 2,854,488 $ 2,837,354 Accrued compensation and related liabilities 1,469,100 2,006,031 1,625,199 Accrued interest 1,462,941 1,130,519 815,802 Lease liabilities 104,000 — — Notes payable 1,369,856 1,369,856 1,369,856 Convertible notes payable 697,000 697,000 697,000 Derivative liability 15,854,000 — — Total Current Liabilities 24,873,261 8,057,894 7,345,211 LONG-TERM LIABILITIES Convertible notes payable 1,000,000 — — TOTAL LIABILITIES 25,873,261 8,057,894 7,345,211 STOCKHOLDERS’ DEFICIT Series A preferred stock 13 13 13 Common stock 341,529 341,529 341,529 Additional paid-in capital 30,712,228 30,610,179 30,599,931 Accumulated deficit (49,941,101 ) (35,744,004 ) (35,017,574 ) Total Stockholders' Deficit (18,887,331 ) (4,792,283 ) (4,076,101 ) TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT $ 6,985,930 $ 3,265,611 $ 3,269,110 CONSOLIDATED BALANCE SHEETS (Unaudited) As of March 31, 2016 ASSETS CURRENT ASSETS Cash and cash equivalents $ 2,256 Accounts receivable 13,595 Inventory 25,921 Other current assets 100,149 Total Current Assets 141,921 PROPERTY AND EQUIPMENT, NET 7,094 RIGHT-OF-USE ASSET — INTANGIBLE ASSETS, NET 3,421,191 OTHER NONCURRENT ASSETS 2,626 TOTAL ASSETS $ 3,572,832 LIABILITIES AND STOCKHOLDERS' DEFICIT CURRENT LIABILITIES Accounts payable and accrued expenses $ 3,060,695 Accrued compensation and related liabilities 1,435,216 Accrued interest 528,573 Notes payable 1,369,856 Convertible notes payable 697,000 Derivative liability 106,000 Total Current Liabilities 7,197,340 LONG-TERM LIABILITIES Accrued interest payable — Accrued return on noncontrolling interest — Mortgage notes payable — Total Long-Term Liabilities — STOCKHOLDERS' DEFICIT Series A preferred stock 13 Common stock 341,405 Additional paid-in capital 30,559,890 Accumulated deficit (34,629,719 ) Accumulated other comprehensive income 103,903 Total Stockholders' Deficit (3,624,508 ) TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 3,572,832 CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) For the three months ended March 31, 2019 2018 2017 REVENUE $ — $ — $ 50,334 OPERATING EXPENSES General and administrative 1,027,577 126,664 216,869 Amortization of intangible assets 61,307 61,307 61,307 Preliminary stage acquisition costs 934,243 — — Total Operating Expenses 2,023,127 187,971 278,176 OPERATING LOSS (2,023,127 ) (187,971 ) (227,842 ) OTHER INCOME (EXPENSE) Other Income (Expense) — 425,000 — Interest expense, net (90,529 ) (80,631 ) (77,302 ) Gain on settlement of liabilities — — — Change in fair value derivative and finance charges related to derivative liability (3,937,000 ) 344,369 — Other Income (Expense), Net (4,027,529 ) — (77,302 ) NET (LOSS)/INCOME $ (6,050,656 ) $ 156,398 $ (305,144 ) BASIC AND DILUTED LOSS PER COMMON SHARE: Net Loss per Common Share $ (0.02 ) $ 0.00 $ (0.00 ) BASIC AND DILUTED WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING 341,529,434 341,529,434 341,529,434 CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) For the three months ended March 31, 2016 REVENUE $ 121,647 OPERATING EXPENSES General and administrative 454,060 Other operating — Total Operating Expenses 454,060 OPERATING LOSS (332,413 ) OTHER INCOME (EXPENSE) Other Income (Expense) (12,820 ) Interest expense, net (73,517 ) Gain on settlement of liabilities — Change in fair value derivative — Foreign currency transaction gain (loss) — Total Other Income (Expense) (86,337 ) NET LOSS $ (418,750 ) CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) For the three months ended March 31, 2019 2018 2017 Operating Activities: Net loss $ (6,050,656 ) $ 156,398 $ (305,144 ) Adjustments to reconcile net loss to net cash used in operating activities: Gain on settlement of liabilities — — — Share-based compensation 43,008 10,248 35,560 Depreciation and amortization 61,306 61,307 61,307 Change in fair value of derivative liability 3,397,000 — — Changes in operating assets and liabilities: Accounts receivable — — 112,254 Inventory — — — Accounts payable and accrued expenses 858,863 (26,427 ) 32,130 Accrued compensation and related liabilities (21 ) — 26,944 Interest payable 90,528 80,631 78,029 Other Operating Activities — — — Net Cash Used in Operating Activities (1,059,972 ) 282,157 41,080 Investing Activities: Pre-acquisition costs — — — Cash received from derivative forward contract — — — Net Cash Used in Investing Activities — — — Financing Activities: Debt issuance costs — — — Proceeds from exercise of stock options — — — Net Cash Used in Financing Activities — — — Net Change in Cash and Cash Equivalents (1,059,972 ) 282,157 41,080 Cash and Cash Equivalents at Beginning of Period 5,226,489 3,733 22,164 Cash and Cash Equivalents at End of Period $ 4,166,517 $ 285,890 $ 63,244 CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) For the three months ended March 31, 2016 Operating Activities: Net loss $ (418,750 ) Adjustments to reconcile net loss to net cash used in operating activities: Foreign currency transaction gain — Gain on settlement of liabilities — Share-based compensation 26,705 Write-down of long-lived assets Depreciation and amortization 62,096 Amortization of debt discount — Change in fair value of derivative liability — Changes in operating assets and liabilities: Accounts receivable — Inventory 623 Accounts payable and accrued expenses 150,185 Accrued compensation and related liabilities — Interest payable — Other Operating Activities — Other noncurrent assets — Other current assets (4,460 ) Net Cash Used in Operating Activities: (183,601 ) Cash Flows of discontinued operations: Operating cash flows 153,758 Investing cash flows — Financing cash flows (including cash at year-end) — Net Cash flows from discontinued operations 153,758 Effect of exchange rate changes on cash (2,605 ) Net Change in Cash and Cash Equivalents (32,448 ) Cash and Cash Equivalents at Beginning of Period 34,704 Cash and Cash Equivalents at End of Period $ 2,256 CONSOLIDATED BALANCE SHEETS (Unaudited) As of June 30, 2019 2018 2017 ASSETS CURRENT ASSETS Cash and cash equivalents $ 2,275,500 $ 161,014 $ 64,978 Accounts receivable — 19,082 25,081 Inventory 22,942 22,942 22,942 Total Current Assets 2,298,442 203,038 113,001 PROPERTY AND EQUIPMENT, NET 1,706 1,706 1,706 RIGHT-OF-USE ASSET 98,000 — — INTANGIBLE ASSETS, NET 2,624,205 2,869,432 3,114,659 DEBT ISSUANCE COSTS 100,000 — — PRE-ACQUISITION COSTS 755,382 — — DEPOSITS 505,253 5,253 5,253 TOTAL ASSETS $ 6,382,988 $ 3,079,429 $ 3,234,619 LIABILITIES AND STOCKHOLDERS' DEFICIT CURRENT LIABILITIES Accounts payable and accrued expenses $ 3,939,808 $ 2,808,299 $ 2,879,783 Accrued compensation and related liabilities 1,469,100 2,003,482 1,652,143 Accrued interest 1,553,470 1,211,150 967,545 Lease liabilities 98,000 — — Notes payable 1,369,856 1,369,856 1,369,856 Convertible notes payable 697,000 697,000 697,000 Derivative liability 14,536,000 — — Total Current Liabilities 23,663,234 8,089,787 7,566,327 LONG-TERM LIABILITIES Convertible notes payable 1,000,000 — — TOTAL LIABILITIES 24,663,234 8,089,787 7,566,327 STOCKHOLDERS' DEFICIT Series A preferred stock 13 13 13 Common stock 341,529 341,529 341,529 Additional paid-in capital 31,179,041 30,669,220 30,599,931 Accumulated deficit (49,800,829 ) (36,021,120 ) (35,273,181 ) Total Stockholders' Deficit (18,280,246 ) (5,010,358 ) (4,331,708 ) TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 6,382,988 $ 3,079,429 $ 3,234,619 CONSOLIDATED BALANCE SHEETS (Unaudited) As of June 30, 2016 ASSETS CURRENT ASSETS Cash and cash equivalents $ 12,205 Accounts receivable 62,924 Inventory 24,431 Other current assets — Total Current Assets 99,560 PROPERTY AND EQUIPMENT, NET 5,453 RIGHT-OF-USE ASSET — INTANGIBLE ASSETS, NET 3,359,885 OTHER NONCURRENT ASSETS 2,626 TOTAL ASSETS $ 3,467,524 LIABILITIES AND STOCKHOLDERS’ DEFICIT CURRENT LIABILITIES Accounts payable and accrued expenses $ 3,011,834 Accrued compensation and related liabilities 1,228,969 Accrued interest 633,173 Notes Payable 1,369,856 Convertible notes payable 697,000 Derivative liability — Total Current Liabilities 6,940,832 LONG-TERM LIABILITIES Accrued interest payable — Accrued return on non-controlling interest — Mortgage notes payable — Total Long-Term Liabilities — TOTAL LIABILITIES 6,940,832 STOCKHOLDERS’ DEFICIT Series A preferred stock 13 Common stock 341,529 Additional paid-in capital 30,564,371 Accumulated deficit (34,379,221 ) Accumulated other comprehensive income — Total Stockholders' Deficit (3,473,308 ) Noncontrolling interests — TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT $ 3,467,524 CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) For the three months ended June 30, 2019 2018 2017 Revenue $ — $ — $ 109,539 Operating Expenses General and Administrative 937,765 135,178 179,566 Amortization of intangible assets 61,306 61,306 61,306 Preliminary stage acquisition costs 82,693 — — Total Operating Expenses 1,081,764 196,484 240,872 Operating Loss (1,081,764 ) (196,484 ) (131,333 ) Other Income (Expense) Other Income (Expenses) — — 28,279 Interest expense, net (89,546 ) (80,632 ) (152,553 ) Gain on settlement of liabilities — — — Change in fair value derivative and finance — — — charges related to derivative liability 1,318,000 — — Other Income (Expense), Net 1,228,454 (80,632 ) (124,274 ) Net (Loss)/Income $ 149,690 $ (277,116 ) $ (255,607 ) Basic and diluted Loss per Common Share: Net Loss per Common Share $ (0.00 ) $ 0.00 $ (0.00 ) Basic and diluted Weighted-Average Common Shares Outstanding 341,546,009 341,529,434 341,529,434 CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) For the three months ended June 30, 2016 Revenue $ 79,583 Operating Expenses — General and Administrative 401,838 Other Operating — Total Operating Expenses 401,838 Operating Loss (322,255 ) Other Income (Expense) Other Income (Expense) 67,349 Interest expense, net (138,770 ) Gain on settlement of liabilities 537,612 Change in fair value derivative — Foreign currency transaction gain (loss) 106,563 Total Other Income (Expense), Net 572,753 Loss from Continuing Operations 250,498 Loss from Discontinued Operations — Net (Loss)/Income $ 250,498 Basic and diluted Loss per Common Share: Net Loss per Common Share $ (0.00 ) Basic and diluted Weighted-Average Common Shares Outstanding 341,529,434 CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) For the six months ended June 30, 2019 2018 2017 Revenue $ — $ — $ 159,873 Operating Expenses General and Administrative 1,065,342 261,842 396,434 Amortization of intangible assets 122,613 122,613 122,613 Preliminary stage acquisition costs 1,016,936 — — Total Operating Expenses 3,104,891 384,455 519,047 Operating Loss (3,104,891 ) (384,455 ) (359,174 ) Other Income (Expense) Other Income (Expense) — 425,000 28,279 Interest expense, net (180,075 ) (161,263 ) (229,856 ) Gain on settlement of liabilities — — — Change in fair value derivative and finance charges related to derivative liability (2,619,000 ) — — Other Income (Expense), Net (2,799,075 ) 263,737 (201,577 ) Net Loss $ (5,903,966 ) $ (120,718 ) $ (560,751 ) Basic and diluted Loss per Common Share: Net Loss per Common Share $ (0.02 ) $ (0.00 ) $ (0.00 ) Basic and diluted Weighted-Average Common Shares Outstanding 341,546,009 341,529,434 341,529,434 CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) For the six months ended June 30, 2016 Revenue $ 201,230 Operating Expenses General and Administrative 855,898 Other operating — Total Operating Expenses 855,899 Operating Loss (654,668 ) Other Income (Expense) Other Income (Expense) 54,528 Interest expense, net (212,287 ) Gain on settlement of liabilities 537,612 Change in fair value derivative — Foreign currency transaction gain (loss) 105,563 Total Other Income (Expense), Net 486,416 Net Loss $ (168,252 ) Basic and diluted Loss per Common Share: Net Loss per Common Share $ (0.00 ) Basic and diluted Weighted-Average Common Shares Outstanding 341,149,556 Statement of Comprehensive Income Net Loss $ (168,252 ) Other comprehensive loss-foreign currency translation adjustment — Comprehensive Loss $ (168,252 ) CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) For the three months ended June 30, 2019 2018 2017 Operating Activities: Net loss $ 146,690 $ (277,116 ) $ (255,607 ) Adjustments to reconcile net loss to net cash used in operating activities: Gain on settlement of liabilities — — — Share-based compensation 460,395 59,041 — Depreciation and amortization 61,307 61,306 61,306 Change in fair value of derivative liability (1,318,000 ) — — Changes in operating assets and liabilities: Accounts receivable — — (25,081 ) Inventory — — — Accounts payable and accrued expenses 23,444 (46,189 ) 42,429 Accrued compensation and related liabilities — (2,549 ) 26,944 Interest payable 90,529 80,631 151,743 Other Operating Activities — — — Net Cash Used in Operating Activities (535,635 ) (124,876 ) 1,734 Investing Activities: Pre-acquisition costs and deposits (1,255,382 ) — — Cash received from derivative forward contract — — — Net Cash Used in Investing Activities (1,255,382 ) — — Financing Activities: Debt issuance costs (100,000 ) — — Proceeds from exercise of stock options — — — Net Cash Used in Financing Activities (100,000 ) — — Net change in Cash and Cash Equivalents (1,891,017 ) (124,876 ) 1,734 Cash and Cash Equivalents at Beginning of Period 4,166,517 285,890 63,244 Cash and Cash Equivalents at End of Period $ 2,275,500 $ 161,014 $ 64,978 CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) For the three months ended June 30, 2016 Operating Activities: Net loss $ 250,498 Adjustments to reconcile net loss to net cash used in operating activities: Foreign currency transaction gain — Gain on settlement of liabilities (255,752 ) Share-based compensation 4,606 Write-down of long lived assets — Depreciation and amortization 62,933 Amortization of debt discount — Change in fair value of derivative (106,000 ) Changes in operating assets and liabilities: Accounts receivable (52,764 ) Inventory 1,490 Accounts payable and accrued expenses (179,963 ) Accrued compensation and related liabilities 104,566 Interest payable 178,144 Other Operating Activities — Other noncurrent assets — Other current assets 41,306 Net Cash Used in Operating Activities 49,063 Investing Activities: Plantation developments costs Net Cash Used in Investing Activities — Financing Activities: Proceeds from issuance of preferred membership in GCE Mexico I, LLC — Net Cash Provided by Financing Activities — Cash Flows of discontinued operations: Operating cash flows 64,257 Investing cash flows — Financing cash flows (including cash at year-end) — Net Cash flows from discontinued operations 64,257 Effect of exchange rate changes on cash (103,371 ) Net change in Cash and Cash Equivalents 9,949 Cash and Cash Equivalents at Beginning of Period 2,256 Cash and Cash Equivalents at End of Period $ 12,205 CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) For the six months ended June 30, 2019 2018 2017 Operating Activities: Net loss $ (5,903,966 ) $ (120,718 ) $ (560,751 ) Adjustments to reconcile net loss to net cash used in operating activities: Gain on settlement of liabilities — — — Share-based compensation 503,403 69,289 35,560 Depreciation and amortization 122,613 122,613 122,613 Change in fair value of derivative liability 2,619,000 — — Changes in operating assets and liabilities: Accounts receivable — — 87,173 Inventory — — — Accounts payable and accrued expenses 882,307 (72,616 ) 74,559 Accrued compensation and related liabilities (21 ) (2,549 ) 53,889 Interest payable 181,057 161,262 229,771 Other Operating Activities — — — Net Cash Used in Operating Activities (1,595,607 ) 157,281 42,814 Investing Activities: Pre-acquisition costs and deposits (1,255,382 ) — — Net Cash Used in Investing Activities (1,255,382 ) — — Financing Activities: Debt issuance costs (100,000 ) — — Proceeds from exercise of stock options — — — Net Cash Used in Financing Activities (100,000 ) — — Net change in Cash and Cash Equivalents (2,950,989 ) 157,281 42,814 Cash and Cash Equivalents at Beginning of Period 5,226,489 3,733 22,164 Cash and Cash Equivalents at End of Period $ 2,275,500 $ 161,014 $ 64,978 CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) For the six months ended June 30, 2016 Operating Activities: Net loss $ (168,252 ) Adjustments to reconcile net loss to net cash used in operating activities: Foreign currency transaction gain — Gain on settlement of liabilities (255,752 ) Share-based compensation 31,311 Depreciation and amortization 125,029 Amortization of debt discount — Change in fair value of derivative (106,000 ) Changes in operating assets and liabilities: Accounts receivable (52,764 ) Inventory 2,113 Accounts payable and accrued expenses (29,778 ) Accrued compensation and related liabilities 104,566 Interest payable 178,144 Other current assets 36,846 Other noncurrent assets — Net Cash Used in Operating Activities (134,538 ) Investing Activities: Plantation developments costs — Net Cash Used in Investing Activities — Financing Activities: Proceeds from issuance of preferred membership in GCE Mexico I, LLC — Net Cash Provided by Financing Activities — Cash Flows of discontinued operations: Operating cash flows 218,015 Investing cash flows — Financing cash flows (including cash at year-end) — Net Cash flows from discontinued operations 218,015 Effect of exchange rate changes on cash (105,976 ) Net change in Cash and Cash Equivalents (22,499 ) Cash and Cash Equivalents at Beginning of Period 34,704 Cash and Cash Equivalents at End of Period $ 12,205 CONSOLIDATED BALANCE SHEETS (Unaudited) As of September 30, 2019 2018 2017 ASSETS CURRENT ASSETS Cash and cash equivalents $ 217,214 $ 57,414 $ 70,996 Accounts receivable — 19,082 — Inventory 22,942 22,942 22,942 Total Current Assets 240,156 99,438 93,938 PROPERTY AND EQUIPMENT, NET 1,706 1,706 1,706 RIGHT-OF-USE ASSET 89,911 — — INTANGIBLE ASSETS, NET 2,562,899 2,808,125 3,053,352 DEBT ISSUANCE COSTS 250,000 — — PRE-ACQUISITION COSTS 1,861,481 — — DEPOSITS 1,005,253 5,253 5,253 TOTAL ASSETS $ 6,011,406 $ 2,914,522 $ 3,154,249 LIABILITIES AND STOCKHOLDERS' DEFICIT CURRENT LIABILITIES Accounts payable and accrued expenses $ 3,779,971 $ 2,832,289 $ 2,944,450 Accrued compensation and related liabilities 1,469,100 2,003,482 1,679,087 Accrued interest 1,643,998 1,291,782 1,008,717 Lease liabilities 90,083 — — Notes payable 1,369,856 1,369,856 1,369,856 Convertible notes payable 1,697,000 697,000 697,000 Derivative liability 14,130,000 — — Total Current Liabilities 24,180,008 8,194,409 7,699,110 LONG-TERM LIABILITIES Convertible notes payable — — — TOTAL LIABILITIES 24,180,008 8,194,409 7,699,110 STOCKHOLDERS' DEFICIT Series A preferred stock 13 13 13 Common stock 344,029 341,529 341,529 Additional paid-in capital 31,216,468 30,669,220 30,599,931 Accumulated deficit (49,729,112 ) (36,290,649 ) (35,486,334 ) Total Stockholders' Deficit (18,168,602 ) (5,279,887 ) (4544,861 ) TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 6,011,406 $ 2,914,522 $ 3,154,249 CONSOLIDATED BALANCE SHEETS (Unaudited) As of September 30, 2016 ASSETS CURRENT ASSETS Cash and cash equivalents $ 17,179 Accounts receivable 87,589 Inventory 23,686 Other current assets — Total Current Assets 128,454 PROPERTY AND EQUIPMENT, NET 3,812 RIGHT-OF-USE ASSET — INTANGIBLE ASSETS, NET 3,298,578 OTHER NONCURRENT ASSETS 5,253 TOTAL ASSETS $ 3,436,097 LIABILITIES AND STOCKHOLDERS' DEFICIT CURRENT LIABILITIES Accounts payable and accrued expenses $ 2,917,748 Accrued compensation and related liabilities 1,283,056 Accrued interest 685,474 Notes Payable 1,369,856 Convertible notes payable 697,000 Derivative liability — Total Current Liabilities 6,953,134 LONG-TERM LIABILITIES Accrued interest payable — Accrued return on non-controlling interest — Mortgage notes payable — Total Long-Term Liabilities 6,953,134 TOTAL LONG-TERM LIABILITIES 6,953,134 STOCKHOLDERS' DEFICIT Series A preferred stock 13 Common stock 341,529 Additional paid-in capital 30,564,371 Accumulated deficit (34,422,950 ) Accumulated other comprehensive income — Total Stockholders' Deficit (3,517,037 ) Noncontrolling interests — TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 3,436,097 CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) For the three months ended September 30, 2019 2018 2017 Revenue $ — $ — $ 179,288 Operating Expenses General and Administrative 126,509 127,591 289,158 Amortization of intangible assets 61,307 61,307 61,307 Preliminary stage acquisition costs 106,381 — — Total Operating Expenses 294,197 188,898 350,465 Operating Loss (294,197 ) (188,898 ) (171,177 ) Other Income (Expense) Other Income (Expense) — — — Interest expense, net (89,401 ) (80,631 ) (41,976 ) Gain on settlement of liabilities — — — Change in fair value derivative and finance — — — charges related to derivative liability 406,000 — — Other Income (Expense), Net 316,599 (80,631 ) (41,976 ) Net (Loss)/Income $ 22,402 (269,529 ) (213,153 ) Basic and diluted Loss per Common Share: Net Loss per Common Share (0.00 ) (0.00 ) (0.00 )         Basic and diluted Weighted-Average Common Shares Outstanding 341,529,434 341,529,434 341,529,434 CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) For the three months ended September 30, 2016 Revenue $ 117,087 Operating Expenses General and Administrative 150,299 Other Operating — Total Operating Expenses 150,299 Operating Loss (33,212 ) Other Income (Expense) Other Income (Expense) 3,635 Interest expense, net (14,152 ) Gain on settlement of liabilities — Change in fair value derivative — Foreign currency transaction gain (loss) — Total Other Income (Expense), Net (10,517 ) Loss from Continuing Operations (43,729 ) Loss from Discontinued Operations — Net Loss $ (43,729 ) Basic and diluted Loss per Common Share: Net Loss per Common Share $ (0.00 ) Basic and diluted Weighted-Average Common Shares Outstanding 341,529,454 Statement of Comprehensive Income Net Loss $ (43,729 ) Other comprehensive income (loss)-foreign currency translation adjustment — Comprehensive Loss $ (43,729 ) CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) For the nine months ended September 30, 2019 2018 2017 Revenue $ — $ — $ 339,161 Operating Expenses General and Administrative 2,048,954 389,433 685,592 Amortization of intangible assets 183,920 183,920 183,920 Preliminary stage acquisition costs 1,123,317 — — Total Operating Expenses 3,356,191 573,353 869,512 Operating Loss (3,356,191 ) (573,353 ) (530,351 ) Other Income (Expense) Other Income (Expense) — 425,000 28,279 Interest expense, net (269,476 ) (241,894 ) (271,832 ) Gain on settlement of liabilities — — — Change in fair value derivative and finance — — — charges related to derivative liability (2,213,000 ) — — Other Income (Expense), Net (2,482,476 ) (183,106 ) (243,553 ) Net Loss $ (5,838,667 ) $ (390,247 ) $ (773,904 ) Basic and diluted Loss per Common Share: Net Loss per Common Share $ (0.02 ) $ (0.00 ) $ (0.00 ) Basic and diluted Weighted-Average Common Shares Outstanding 342,208,921 341,529,434 341,529,434 CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) For the nine months ended September 30, 2016 Revenue $ 318,317 Operating Expenses General and Administrative 1,006,197 Other Operating — Total Operating Expenses 1,006,197 Operating Loss (687,880 ) Other Income (Expense) Other Income (Expense) 58,163 Interest expense, net (226,439 ) Gain on settlement of liabilities 537,612 Change in fair value derivative — Foreign currency transaction gain (loss) 106,563 Total Other Income (Expense), Net 475,899 Net Loss $ (211,981 ) Basic and diluted Loss per Common Share: Net Loss per Common Share $ (0.00 ) Basic and diluted Weighted-Average Common Shares Outstanding 341,529,454 Statement of Comprehensive Income Net Loss $ (211,981 ) Other comprehensive income (loss)-foreign currency translation adjustment — Comprehensive Loss $ (211,981 ) CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) For the three months ended September 30, 2019 2018 2017 Operating Activities: Net loss $ 22,402 $ (269,529 ) $ (213,153 ) Adjustments to reconcile net loss to net cash used in operating activities: Gain on settlement of liabilities — — — Share-based compensation 71,742 — — Depreciation and amortization 61,306 61,307 61,307 Change in fair value of derivative liability (406,000 ) — — Changes in operating assets and liabilities: Accounts receivable — — 25,081 Inventory — — — Accounts payable and accrued expenses (159,665 ) 23,990 64,667 Accrued compensation and related liabilities — — 26,944 Interest payable 90,528 80,632 41,171 Other Operating Activities — — — Net Cash Used in Operating Activities (319,687 ) (103,600 ) 6,018 Investing Activities: Pre-acquisition costs and deposits (1,606,099 ) — — Cash received from derivative forward contract — — — Net Cash Used in Investing Activities (1,606,099 ) — — Financing Activities: Debt issuance costs (150,000 ) — — Proceeds from exercise of stock options 17,500 — — Net Cash Used in Financing Activities 132,500 — — Net change in Cash and Cash Equivalents (2,058,286 ) (103,599 ) 6,018 Cash and Cash Equivalents at Beginning of Period 2,275,500 161,014 64,978 Cash and Cash Equivalents at End of Period $ 217,214 $ 57,415 $ 70,996 CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) For the three months ended September 30, 2016 Operating Activities: Net loss $ (43,729 ) Adjustments to reconcile net loss to net cash used in operating activities: Foreign currency transaction gain — Gain on settlement of liabilities — Share-based compensation — Write-down of long lived assets — Loss on disposal of fixed assets — Depreciation and amortization 62,947 Amortization of debt discount — Change in fair value of derivative — Changes in operating assets and liabilities: Accounts receivable (24,665 ) Inventory (745 ) Accounts payable and accrued expenses (94,086 ) Accrued compensation and related liabilities 54,087 Interest payable 52,301 Other Operating Activities — Other current assets (2,627 ) Other noncurrent assets — Net Cash Used in Operating Activities 4,974 Investing Activities: Plantation developments costs — Proceeds from sale of property and equipment — Net Cash Used in Investing Activities — Financing Activities: Proceeds from issuance of preferred membership in GCE Mexico I, LLC — Net Cash Provided by Financing Activities — Cash Flows of discontinued operations: Operating cash flows Investing cash flows — Financing cash flows (including cash at year-end) — Net Cash flows from discontinued operations — Effect of exchange rate changes on cash — Net Change in Cash and Cash Equivalents 4,974 Cash and Cash Equivalents at Beginning of Period 12,205 Cash and Cash Equivalents at End of Period $ 17,179 CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) For the nine months ended September 30, 2019 2018 2017 Operating Activities: Net loss $ (5,881,564 ) $ (390,247 ) $ (773,904 ) Adjustments to reconcile net loss to net cash used in operating activities: Gain on settlement of liabilities — — — Share-based compensation 575,145 69,289 35,560 Depreciation and amortization 183,919 183,920 183,920 Change in fair value of derivative liability 2,213,000 — — Changes in operating assets and liabilities: Accounts receivable — — 112,254 Inventory — — — Accounts payable and accrued expenses 722,642 (48,626 ) 139,226 Accrued compensation and related liabilities (21 ) (2,549 ) 80,833 Interest payable 271,585 241,894 270,943 Other Operating Activities — — — Net Cash Used in Operating Activities (1,915,294 ) 53,681 48,832 Investing Activities: Pre-acquisition costs and deposits (2,861,481 ) Net Cash Used in Investing Activities (2,861,481 ) — — Financing Activities: Debt issuance costs (250,000 ) Proceeds from exercise of stock options 17,500 — — Net Cash Used in Financing Activities (232,500 ) — — Net Change in Cash and Cash Equivalents (5,009,275 ) 53,681 48,832 Cash and Cash Equivalents at Beginning of Period 5,226,489 3,733 22,164 Cash and Cash Equivalents at End of Period $ 217,214 $ 57,414 $ 70,996 CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) For the nine months ended September 30, 2016 Operating Activities: Net loss $ (211,981 ) Adjustments to reconcile net loss to net cash used in operating activities: Foreign currency transaction gain — Gain on settlement of liabilities (255,752 ) Share-based compensation 31,311 Write-down of long-lived assets — Loss on disposal of fixed assets — Depreciation and amortization 187,976 Amortization of debt discount — Change in fair value of derivative (106,000 ) Changes in operating assets and liabilities: Accounts receivable (77,429 ) Inventory 2,858 Accounts payable and accrued expenses (123,864 ) Accrued compensation and related liabilities 158,653 Interest payable 230,445 Other current assets 34,219 Other noncurrent assets — Net Cash Used in Operating Activities (129,564 ) Investing Activities: Plantation developments costs — Proceeds from sale of property and equipment — Net Cash Used in Investing Activities — Financing Activities: Proceeds from issuance of preferred membership in GCE Mexico I, LLC Net Cash Provided by Financing Activities — Cash Flows of discontinued operations: Operating cash flows 218,015 Investing cash flows — Financing cash flows (including cash at year-end) — Net Cash flows from discontinued operations 218,015 Effect of exchange rate changes on cash (105,976 ) Net Change in Cash and Cash Equivalents (17,525 ) Cash and Cash Equivalents at Beginning of Period 34,704 Cash and Cash Equivalents at End of Period $ 17,179

ORGANIZATION AND SIGNIFICANT _2

ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
Description of Business	Description of Business Global Clean Energy Holdings, Inc., a Delaware corporation, and its wholly owned subsidiaries (collectively, the “Company”) is a U.S.-based integrated agricultural-energy biofuels company, and together with its subsidiaries holds assets across feedstocks and plant genetics, agronomics, cultivation, and regulatory approvals, commercialization, and downstream biorefining and storage. The Company is focused on the development and refining of non-food based bio-feedstocks and has a proprietary investment in Camelina sativa (“Camelina”), a fast growing, low input and ultra-low carbon intensity crop used as a feedstock for renewable fuels. In 2018 and 2019 the Company pursued the acquisition of a crude oil refinery in Bakersfield, California with the objective of retrofitting it to produce renewable diesel from Camelina and other non-food feedstocks. Subsequent to year end 2019, the Company completed the acquisition of the targeted refinery. The retrofitting of the refinery is expected to be completed in the first quarter of 2022. The Company has entered into a product offtake agreement with a major oil company for the majority of the renewable diesel that it will produce. See Note B which describes the agreement in more detail.
Basis of Presentation	Basis of Presentation The accompanying consolidated financial statements include the accounts of Global Clean Energy Holdings, Inc., and its wholly owned subsidiaries, and have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”). Intercompany accounts and transactions have been eliminated. In the opinion of the Company’s management, the consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation.
Cash and Cash Equivalents; Concentration of Credit Risk	Cash and Cash Equivalents; Concentration of Credit Risk For purposes of the statement of cash flows, the Company had no cash and cash equivalents in excess of federally-insured limits. The Company considers all highly liquid debt instruments maturing in three months or less to be cash equivalents. The Company has maintained its cash balances at what management considers to be high credit-quality financial institutions.
Accounts and Other Receivables	Accounts and Other Receivables Trade receivables are recorded at net realizable value. The allowance for doubtful accounts reflects the Company’s best estimate of probable losses inherent in the accounts receivable balance. The Company determines the allowance based on known troubled accounts, historical experience, and other currently available evidence. The Company reviews its allowance for doubtful accounts quarterly. Past due balances over 90 days and over a specified amount are reviewed individually for collectability. Account balances are charged off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.
Property and Equipment	Property and Equipment Property and equipment are stated at cost. Depreciation of office equipment is computed using the straight-line method over estimated useful lives of 3 to 5 years. Field equipment is depreciated using the straight-line method over estimated useful lives of 5 to 15 years. Normal maintenance and repair items are charged to operating costs and are expensed as incurred. The cost and accumulated depreciation of property and equipment sold or otherwise retired are removed from the accounts and gain or loss on disposition is reflected in results of operations.
Long-Lived Assets	Long-Lived Assets In accordance with U.S. GAAP the carrying values of intangible assets and other long-lived assets are reviewed on a regular basis for the existence of facts or circumstances that may suggest impairment. The Company recognizes impairment when the aggregate of the expected undiscounted future cash flows is less than the carrying amount of the asset. Impairment losses, if any, are measured as the excess of the carrying amount of the asset over its estimated fair value.
Pre-Acquisition Costs	Pre-Acquisition Costs The Company capitalizes its pre-acquisition costs once management determines that it is probable that the project will occur. Probability is determined based on i) management, having the requisite authority, has implicitly or explicitly authorized and committed to funding the acquisition or construction of a specific asset, ii) the financial resources are available consistent with such authorization, and iii) the ability exists to meet the necessary local and other governmental regulations. Cost capitalization occurs when the acquisition is probable. We capitalize those costs that are directly identifiable with the specific property and those costs that would be capitalized if the property were already acquired. We expense general and administrative and overhead costs and costs, including payroll, that would be considered support functions. In 2019, we capitalized $2.6 million of these costs which included financing costs, legal costs, pre-engineering costs and other contractual costs and expenses directly related to the purchase of the Bakersfield refinery in May 2020. In addition, we paid $3.2 million of deposits for the acquisition of the property.
Debt Issuance Costs	Debt Issuance Costs During 2018, we signed a letter of intent to acquire our Bakersfield Refinery. The acquisition of the refinery and the related $365 million of financing to retrofit it closed in May 2020. During 2019, we incurred $0.5 million of costs related to obtaining financing for the Bakersfield Refinery. These debt issuance costs have been deferred and recorded on the balance sheet and will be amortized over the term of the financing. See Note J in Subsequent Events for more detail on the financing.
Derecognition of Liabilities	Derecognition of Liabilities The Company reviews its liabilities, including but not limited to, accounts payable, notes payable, accrued expenses, accrued liabilities and other legal obligations for a determination of the legal enforcement or settlement of an obligation. Upon conclusive evidence that an obligation may be extinguished, has expired, is discharged, cancelled or otherwise no longer legally exists, then the Company will derecognize the respective liability on its balance sheet.
Income Taxes	Income Taxes The Company utilizes the liability method of accounting for income taxes. Under the liability method, deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities and the carryforward of operating losses and tax credits, and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance against deferred tax assets is recorded when it is more likely than not that such tax benefits will not be realized. Assets and liabilities are established for uncertain tax positions taken or positions expected to be taken in income tax returns when such positions are judged to not meet the “more-likely-than-not” threshold based on the technical merits of the positions. Estimated interest and penalties related to uncertain tax positions are included as a component of general and administrative expense.
Revenue Recognition	Revenue Recognition On January 1, 2018, the Company adopted ASU 2014-09 Revenue from Contracts with Customers Prior to the adoption of ASC 606, the Company would recognize revenue when all of the following criteria were met: persuasive evidence of an arrangement exists; delivery occurred or services had been rendered; the seller's price to the buyer is fixed or determinable; collectability was reasonably assured; and title and the risks and rewards of ownership have transferred to the buyer. The Company’s revenues during 2015 – 2017 primarily consisted of contract advisory services, which included development and management services to other companies regarding their bio-fuels and/or feedstock development operations, on a fee for services basis. The advisory services revenue was recognized upon completion of the work in accordance with each advisory contract.
Research and Development	Research and Development Research and development costs are charged to operating expenses when incurred.
Fair Value Measurements and Fair Value of Financial Instruments	Fair Value Measurements and Fair Value of Financial Instruments The carrying amounts of the Company’s financial instruments that are not reported at fair value in the accompanying consolidated balance sheets, including cash and cash equivalents, accounts receivable, accounts payable, and accrued liabilities approximate their carrying value due to their short-term nature. The Company’s derivative liability related to its derivative forward contract is reported at fair value. U.S. GAAP specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect the Company's market assumptions. These two types of inputs have created the following fair-value hierarchy: Level 1— Quoted prices for identical instruments in active markets. Level 2— Quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets; and Level 3— Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. During October 2018, the Company entered into a derivative forward contract that also included a call option. This contract was used as a source of financing, and the Company received $6 million at the inception of the contract from the counterparty. The notional amount of the forward contract related to gallons of the commodity, Ultra Low Sulfur Diesel. Under the terms of the contract the Company was obligated to pay the equivalent of the notional amount multiplied by the market price of Ultra Low Sulfur Diesel at the settlement dates; however, the call option of the contract capped the market price of Ultra Low Sulfur Diesel. At the inception of the contract the fair value of the derivative liability exceeded the $6 million received by the Company, and as a result, the Company recognized a financing cost of $9.1 million. During October 2019, the derivative forward contract was amended, and the Company received an additional $4 million and the notional amount and liability increased accordingly. The derivative forward contract was amended again in April 2020. Under the amendment, the contract was replaced with a fixed payment obligation, whereby the Company agreed to pay the counterparty a total of $24.8 million, which included a payment of $4.5 million in June 2020, and six installment payments in 2022 totaling $20.3 million. The fair value of the derivative forward contract is primarily based upon the notional amount and the forward strip market prices of Ultra Low Sulfur Diesel, and is reduced by the fair value of the call option. The forward strip market prices are observable. However, to determine the fair value of the call option, Company used the Black’s 76 option pricing model. As a result, the contract as a whole is included in the Level 3 of the fair value hierarchy. The following presents changes in the derivative liability: Year Ended Quarter Ended 12/31/19 12/31/19 09/30/19 06/30/19 03/31/19 12/31/18 Beginning Balance $ 11,917,000 $ 14,130,000 $ 14,536,000 $ 15,854,000 $ 11,917,000 $ — New contract / contract additions 4,000,000 4,000,000 — — — 15,114,000 (Gain) loss in fair value recognized in earnings 8,850,000 6,637,000 (406,000 ) (1,318,000 ) 3,937,000 (3,197,000 ) $ 24,767,000 $ 24,767,000 $ 14,130,000 $ 14,536,000 $ 15,854,000 $ 11,917,000 During the quarter ended December 31, 2018, the Company recognized a charge in earnings of $5.9 million related to the derivative forward contract. This charge consisted of $9.1 million finance costs of the derivative, less a decrease in fair value of $3.2 million.
Estimates	Estimates Management uses estimates and assumptions in preparing financial statements. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and reported revenues and expenses. Significant estimates used in preparing these financial statements include a) those assumed in determining the valuation of common stock, warrants, and stock options, b) those assumed in determining the value of the derivative transactions, c) estimated useful lives of equipment and patent costs, and d) undiscounted future cash flows for purpose of evaluating possible impairment of long-term assets. It is at least reasonably possible that the significant estimates used will change within the next year.
Income/Loss Per Common Share	Income/Loss per Common Share Income/Loss per share amounts are computed by dividing income or loss applicable to the common stockholders of the Company by the weighted-average number of common shares outstanding during each period. Diluted income or loss per share amounts are computed assuming the issuance of common stock for potentially dilutive common stock equivalents. The number of dilutive warrants and options is computed using the treasury stock method, whereby the dilutive effect is reduced by the number of treasury shares the Company could purchase with the proceeds from exercises of warrants and options. The following instruments are currently antidilutive and have been excluded from the calculations of diluted income or loss per share at December 31, 2016, 2017, 2018 and 2019, as follows: December 31, 2019 2018 2017 2016 Convertible notes and accrued interest 98,794,390 93,657,637 26,156,533 24,266,533 Convertible preferred stock - Series B 11,818,181 11,818,181 11,818,181 11,818,181 Warrants — — — 3,083,332 Compensation-based stock options and warrants 199,027,315 137,427,315 52,586,692 84,782,003
Stock Based Compensation	Stock Based Compensation The Company recognizes compensation expenses for stock-based awards expected to vest on a straight-line basis over the requisite service period of the award based on their grant date fair value. However, in the case of awards with accelerated vesting, the amount of compensation expense recognized at any date will be based upon the portion of the award that is vested at that date. The Company estimates the fair value of stock options using a Black-Scholes option pricing model which requires management to make estimates for certain assumptions regarding risk-free interest rate, expected life of options, expected volatility of stock and expected dividend yield of stock. For the fiscal years ended December 31, 2019, 2018, 2017 and 2016, charges related to stock-based compensation amounted to approximately $577,645, $68,289, $33,560 and $33,311, respectively. For the fiscal years ended December 31, 2019, 2018, 2017 and 2016, all stock-based compensation is classified in general and administrative expense.
Subsequent Events	Subsequent Events The Company has evaluated subsequent events through October 6, 2020, the date these consolidated financial statements were issued. See Note J to these consolidated financial statements for a description of events occurring subsequent to December 31, 2019.
Recently Issued Accounting Statements	Recently Issued Accounting Statements Revenue Recognition In May 2014, the FASB issued Accounting Standards Update ("ASU") No. 2014-09, Revenue from Contracts with Customers Leasing Effective January 1, 2019 the Company adopted the Financial Accounting Standards Board's ("FASB") Accounting Standards Update No. 2016-02, Leases Stock Compensation In June 2018, the FASB issued ASU No. 2018-07 Improvements to Non-employee Share-based Payment Accounting Compensation - Stock Compensation Equity-Based Payments to Non-employees

ORGANIZATION AND SIGNIFICANT _3

ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Dec. 31, 2019
Accounting Policies [Abstract]
Schedule of changes in derivative liability	The following presents changes in the derivative liability: Year Ended Quarter Ended Quarter Ended 12/31/19 12/31/19 09/30/19 06/30/19 03/31/19 12/31/18 Beginning Balance $ 11,917,000 $ 14,130,000 $ 14,536,000 $ 15,854,000 $ 11,917,000 $ — New contract / contract additions 4,000,000 4,000,000 — — — 15,114,000 (Gain) loss in fair value recognized in earnings 8,850,000 6,637,000 (406,000 ) (1,318,000 ) 3,937,000 (3,197,000 ) $ 24,767,000 $ 24,767,000 $ 14,130,000 $ 14,536,000 $ 15,854,000 $ 11,917,000
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following instruments are currently antidilutive and have been excluded from the calculations of diluted income or loss per share at December 31, 2016, 2017, 2018 and 2019, as follows: December 31, 2019 2018 2017 2016 Convertible notes and accrued interest 98,794,390 93,657,637 26,156,533 24,266,533 Convertible preferred stock - Series B 11,818,181 11,818,181 11,818,181 11,818,181 Warrants — — — 3,083,332 Compensation-based stock options and warrants 199,027,315 137,427,315 52,586,692 84,782,003

PROPERTY AND EQUIPMENT (Tables)

PROPERTY AND EQUIPMENT (Tables)	12 Months Ended
	Dec. 31, 2019
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment	Property and equipment as of December 31, 2019, 2018, 2017, 2016 and 2015 are as follows: 2019 2018 2017 2016 2015 Field Equipment $ — $ 10,305 $ 10,305 $ 10,305 $ 10,574 Office Equipment 61,078 61,601 61,601 61,601 64,729 Total Cost 61,078 71,906 71,906 71,906 75,303 Less accumulated depreciation 61,078 70,200 70,200 69,736 67,435 Property and equipment, net $ — $ 1,706 $ 1,706 $ 2,170 $ 7,868

PATENT LICENSE FEES (Tables)

PATENT LICENSE FEES (Tables)	12 Months Ended
	Dec. 31, 2019
Notes to Financial Statements
Schedule of patent license assets	The patent license assets as of the year ended December 31, 2019, 2018, 2017, 2016 and 2015 is shown in the following table: December 31 2019 2018 2017 2016 2015 Patent license fees $ 4,187,902 $ 4,186,289 $ 4,168,841 $ 4,168,841 $ 4,168,841 Less accumulated amortization (1,686,3107 ) (1,439,471 ) (1,176,796 ) (931,569 ) (686,343 ) Intangible Assets, Net $ 2,501,592 $ 2,746,818 $ 2,992,045 $ 3,237,272 $ 3,482,498

STOCK OPTIONS AND WARRANTS (Tab

STOCK OPTIONS AND WARRANTS (Tables)	12 Months Ended
	Dec. 31, 2019
Disclosure Text Block [Abstract]
Summary of option award activity and awards outstanding	A summary of the option award activity and awards outstanding at December 31, 2019 is as follows: Shares Under Option Weighted Average Exercise Price Weighted Average Remaining Contractual Life Aggregate Intrinsic Value Outstanding at December 31, 2015 93,208,997 $ 0.015 2.2 years $ — Granted 7,300,000 0.002 Exercised — Forfeited (4,800,000 ) 0.024 — Expired (10,926,994 ) 0.008 — Outstanding at December 31, 2016 84,782,003 0.015 1.7 years   — Granted 3,500,000 0.004 Exercised — Forfeited (7,500,000 ) 0.006 — Expired (28,195,311 ) 0.018 — Outstanding at December 31, 2017 52,586,692 0.013 1.6 years   600 Granted 118,750,000 0.015 Exercised — Forfeited (24,959,377 ) 0.015 — Expired (8,950,000 ) 0.022 — Outstanding at December 31, 2018 137,427,315 0.014 4.4 years   28,260 Granted 66,500,000 0.019 Exercised (2,500,000 ) 0.006 Forfeited — — Expired (2,400,000 ) 0.010 — Outstanding at December 31, 2019 199,027,315 0.016 3.6 years   14,360,463 Vested and exercisable at December 31, 2019 184,964,315 $ 0.016 3.6 years $ 13,468,745
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	The following table illustrates the assumptions used in estimating the fair value of options granted during the periods presented: For the Years Ended December 31, 2019 2018 2017 2016 Expected Term (in Years) 2 to 5 2 to 5 3 to 3.75 3.75 Volatility 123 % 123 % 175%-189% 142%-156% Risk Free Rate 2.8 % 2.8 % 1.9%-2.0% 1.4%-2.0% Dividend Yield 0 % 0 % 0 % 0 % Suboptimal Exercise Factor (1) 1.3 1.3 n/a n/a Exit Rate Pre-vesting (2) 0 % 0 % n/a n/a Exit Rate Post-vesting (3) 0 % 0 % n/a n/a Aggregate Grant Date Fair Value $ 326,644 $ 396,074 $ 12,737 $ 19,038 (1) The suboptimal exercise factor estimates the value realized by the holder upon exercise of the option and the estimated point at which an option holder would exercise an in-the-money option. The Company estimated the suboptimal factor based on the holder realizing a pre-tax profit of $500,000. Used for lattice model purposes only. (2) Assumed forfeiture rate for market condition option awards prior to vesting. Used for lattice model purposes only. (3) Assumed expiration or forfeiture rate for market condition option awards after vesting. Used for lattice model purposes only.

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Dec. 31, 2019
Income Tax Disclosure [Abstract]
Schedule of Components of Income Tax Expense (Benefit	The provisions for income taxes for the years ended December 31, 2019 and 2018 through 2016 are as follows: 2019 2018 2017 2016 2015 Current: Federal $ (265,000 ) $ (418,000 ) $ (127,000 ) $ 110,000 $ (319,000 ) State (123,000 ) (193,000 ) (36,000 ) 31,000 Deferred: Federal (1,992,000 ) (1,111,000 ) (241,000 ) 129,000 140,000 State (920,000 ) (513,000 ) (69,000 ) 37,000 Change in Valuation Allowance 3,300,000 2,235,000 473,000 (307,000 ) 179,000 Provision for income taxes $ — $ — $ — $ — $ —
Schedule of Effective Income Tax Rate Reconciliation	A reconciliation of the federal statutory tax rate to the effective tax rate is as follows: 2019 2018 2017 2016 2015 Federal statutory rate 21 % 21 % 21 % 34 % 34 % State, net of federal tax benefit 6.98 % 6.98 % 6.98 % 5.83 % 5.83 % Effect of permanent differences State return to provision Change in valuation allowance -28 % -28 % -28 % -40 % -40 % Effective tax rate — — — — —
Schedule of Deferred Tax Assets and Liabilities	At December 31, 2019 and 2018 through 2016, the deferred income tax assets consisted of the following: 2019 2018 2017 2016 2015 Deferred tax assets: $ 14,563,000 $ 11,263,000 $ 9,028,000 $ 8,555,000 $ 8,862,000 Less: Valuation Allowance (14,563,000 ) (11,263,000 ) (9,028,000 ) (8,555,000 ) (8,862,000 ) Net deferred income taxes $ — $ — $ — $ — $ —
Schedule of deferred income tax assets for temporary differences	At December 31, 2019 and 2018 through 2016, the deferred income tax assets consisted of the following temporary differences: 2019 2018 2017 2016 2015 Net operating losses $ 8,530,000 $ 8,140,000 $ 7,529,000 $ 7,366,000 $ 7,507,000 Share based compensation 269,000 107,000 87,000 73,000 483,000 Accrued payroll 1,631,000 1,359,000 1,412,000 1,116,000 830,000 Impairment — — — — 42,000 Derivative Liability 4,132,000 1,656,000 — — — Total deferred tax assets 14,562,000 11,262,000 9,028,000 8,555,000 8,862,000 Less: Valuation allowance (14,562,000 ) (11,262,000 ) (9,028,000 ) (8,555,000 ) (8,862,000 ) $ — $ — $ — $ — $ —
Schedule of operating loss carryforwards	At December 31, 2019 through 2016, the Company has federal net operating loss carryforwards of approximately: 2019 2018 2017 2016 2015 Net operating losses $ 21,152,000 $ 19,765,000 $ 17,579,000 $ 17,169,000 $ 17,523,343

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	12 Months Ended
	Dec. 31, 2019
Disclosure Text Block [Abstract]
Schedule of Future Minimum Rental Payments for Operating Leases	Operating Year Ending Gross Less: Discount Lease December 31, Payments Discount Obligation 2020 $ 34,000 $ 5,000 $ 29,000 2021 35,000 3,000 32,000 2022 20,000 1,000 19,000 Total $ 89,000 $ 9,000 $ 80,000

QUARTERLY FINANCIAL DATA (Una_2

QUARTERLY FINANCIAL DATA (Unaudited) (Tables)	12 Months Ended
	Dec. 31, 2019
Quarterly Financial Information Disclosure [Abstract]
Quarterly Financial Information	CONSOLIDATED BALANCE SHEETS (Unaudited) As of March 31, 2019 2018 2017 ASSETS CURRENT ASSETS Cash and cash equivalents $ 4,166,517 $ 285,890 $ 63,244 Accounts receivable — 19,082 — Inventory 22,942 22,942 22,942 Total Current Assets 4,189,459 327,914 86,186 PROPERTY AND EQUIPMENT, NET 1,706 1,706 1,706 RIGHT-OF-USE ASSET 104,000 — — INTANGIBLE ASSETS, NET 2,685,512 2,930,738 3,175,965 DEBT ISSUANCE COSTS — — — PRE-ACQUISITION COSTS — — — DEPOSITS 5,253 5,253 5,253 TOTAL ASSETS $ 6,985,930 $ 3,265,611 $ 3,269,110 LIABILITIES AND STOCKHOLDERS’ DEFICIT CURRENT LIABILITIES Accounts payable and accrued expenses $ 3,916,364 $ 2,854,488 $ 2,837,354 Accrued compensation and related liabilities 1,469,100 2,006,031 1,625,199 Accrued interest 1,462,941 1,130,519 815,802 Lease liabilities 104,000 — — Notes payable 1,369,856 1,369,856 1,369,856 Convertible notes payable 697,000 697,000 697,000 Derivative liability 15,854,000 — — Total Current Liabilities 24,873,261 8,057,894 7,345,211 LONG-TERM LIABILITIES Convertible notes payable 1,000,000 — — TOTAL LIABILITIES 25,873,261 8,057,894 7,345,211 STOCKHOLDERS’ DEFICIT Series A preferred stock 13 13 13 Common stock 341,529 341,529 341,529 Additional paid-in capital 30,712,228 30,610,179 30,599,931 Accumulated deficit (49,941,101 ) (35,744,004 ) (35,017,574 ) Total Stockholders' Deficit (18,887,331 ) (4,792,283 ) (4,076,101 ) TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT $ 6,985,930 $ 3,265,611 $ 3,269,110 CONSOLIDATED BALANCE SHEETS (Unaudited) As of March 31, 2016 ASSETS CURRENT ASSETS Cash and cash equivalents $ 2,256 Accounts receivable 13,595 Inventory 25,921 Other current assets 100,149 Total Current Assets 141,921 PROPERTY AND EQUIPMENT, NET 7,094 RIGHT-OF-USE ASSET — INTANGIBLE ASSETS, NET 3,421,191 OTHER NONCURRENT ASSETS 2,626 TOTAL ASSETS $ 3,572,832 LIABILITIES AND STOCKHOLDERS' DEFICIT CURRENT LIABILITIES Accounts payable and accrued expenses $ 3,060,695 Accrued compensation and related liabilities 1,435,216 Accrued interest 528,573 Notes payable 1,369,856 Convertible notes payable 697,000 Derivative liability 106,000 Total Current Liabilities 7,197,340 LONG-TERM LIABILITIES Accrued interest payable — Accrued return on noncontrolling interest — Mortgage notes payable — Total Long-Term Liabilities — STOCKHOLDERS' DEFICIT Series A preferred stock 13 Common stock 341,405 Additional paid-in capital 30,559,890 Accumulated deficit (34,629,719 ) Accumulated other comprehensive income 103,903 Total Stockholders' Deficit (3,624,508 ) TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 3,572,832 CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) For the three months ended March 31, 2019 2018 2017 REVENUE $ — $ — $ 50,334 OPERATING EXPENSES General and administrative 1,027,577 126,664 216,869 Amortization of intangible assets 61,307 61,307 61,307 Preliminary stage acquisition costs 934,243 — — Total Operating Expenses 2,023,127 187,971 278,176 OPERATING LOSS (2,023,127 ) (187,971 ) (227,842 ) OTHER INCOME (EXPENSE) Other Income (Expense) — 425,000 — Interest expense, net (90,529 ) (80,631 ) (77,302 ) Gain on settlement of liabilities — — — Change in fair value derivative and finance charges related to derivative liability (3,937,000 ) 344,369 — Other Income (Expense), Net (4,027,529 ) — (77,302 ) NET (LOSS)/INCOME $ (6,050,656 ) $ 156,398 $ (305,144 ) BASIC AND DILUTED LOSS PER COMMON SHARE: Net Loss per Common Share $ (0.02 ) $ 0.00 $ (0.00 ) BASIC AND DILUTED WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING 341,529,434 341,529,434 341,529,434 CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) For the three months ended March 31, 2016 REVENUE $ 121,647 OPERATING EXPENSES General and administrative 454,060 Other operating — Total Operating Expenses 454,060 OPERATING LOSS (332,413 ) OTHER INCOME (EXPENSE) Other Income (Expense) (12,820 ) Interest expense, net (73,517 ) Gain on settlement of liabilities — Change in fair value derivative — Foreign currency transaction gain (loss) — Total Other Income (Expense) (86,337 ) NET LOSS $ (418,750 ) CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) For the three months ended March 31, 2019 2018 2017 Operating Activities: Net loss $ (6,050,656 ) $ 156,398 $ (305,144 ) Adjustments to reconcile net loss to net cash used in operating activities: Gain on settlement of liabilities — — — Share-based compensation 43,008 10,248 35,560 Depreciation and amortization 61,306 61,307 61,307 Change in fair value of derivative liability 3,397,000 — — Changes in operating assets and liabilities: Accounts receivable — — 112,254 Inventory — — — Accounts payable and accrued expenses 858,863 (26,427 ) 32,130 Accrued compensation and related liabilities (21 ) — 26,944 Interest payable 90,528 80,631 78,029 Other Operating Activities — — — Net Cash Used in Operating Activities (1,059,972 ) 282,157 41,080 Investing Activities: Pre-acquisition costs — — — Cash received from derivative forward contract — — — Net Cash Used in Investing Activities — — — Financing Activities: Debt issuance costs — — — Proceeds from exercise of stock options — — — Net Cash Used in Financing Activities — — — Net Change in Cash and Cash Equivalents (1,059,972 ) 282,157 41,080 Cash and Cash Equivalents at Beginning of Period 5,226,489 3,733 22,164 Cash and Cash Equivalents at End of Period $ 4,166,517 $ 285,890 $ 63,244 CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) For the three months ended March 31, 2016 Operating Activities: Net loss $ (418,750 ) Adjustments to reconcile net loss to net cash used in operating activities: Foreign currency transaction gain — Gain on settlement of liabilities — Share-based compensation 26,705 Write-down of long-lived assets Depreciation and amortization 62,096 Amortization of debt discount — Change in fair value of derivative liability — Changes in operating assets and liabilities: Accounts receivable — Inventory 623 Accounts payable and accrued expenses 150,185 Accrued compensation and related liabilities — Interest payable — Other Operating Activities — Other noncurrent assets — Other current assets (4,460 ) Net Cash Used in Operating Activities: (183,601 ) Cash Flows of discontinued operations: Operating cash flows 153,758 Investing cash flows — Financing cash flows (including cash at year-end) — Net Cash flows from discontinued operations 153,758 Effect of exchange rate changes on cash (2,605 ) Net Change in Cash and Cash Equivalents (32,448 ) Cash and Cash Equivalents at Beginning of Period 34,704 Cash and Cash Equivalents at End of Period $ 2,256 CONSOLIDATED BALANCE SHEETS (Unaudited) As of June 30, 2019 2018 2017 ASSETS CURRENT ASSETS Cash and cash equivalents $ 2,275,500 $ 161,014 $ 64,978 Accounts receivable — 19,082 25,081 Inventory 22,942 22,942 22,942 Total Current Assets 2,298,442 203,038 113,001 PROPERTY AND EQUIPMENT, NET 1,706 1,706 1,706 RIGHT-OF-USE ASSET 98,000 — — INTANGIBLE ASSETS, NET 2,624,205 2,869,432 3,114,659 DEBT ISSUANCE COSTS 100,000 — — PRE-ACQUISITION COSTS 755,382 — — DEPOSITS 505,253 5,253 5,253 TOTAL ASSETS $ 6,382,988 $ 3,079,429 $ 3,234,619 LIABILITIES AND STOCKHOLDERS' DEFICIT CURRENT LIABILITIES Accounts payable and accrued expenses $ 3,939,808 $ 2,808,299 $ 2,879,783 Accrued compensation and related liabilities 1,469,100 2,003,482 1,652,143 Accrued interest 1,553,470 1,211,150 967,545 Lease liabilities 98,000 — — Notes payable 1,369,856 1,369,856 1,369,856 Convertible notes payable 697,000 697,000 697,000 Derivative liability 14,536,000 — — Total Current Liabilities 23,663,234 8,089,787 7,566,327 LONG-TERM LIABILITIES Convertible notes payable 1,000,000 — — TOTAL LIABILITIES 24,663,234 8,089,787 7,566,327 STOCKHOLDERS' DEFICIT Series A preferred stock 13 13 13 Common stock 341,529 341,529 341,529 Additional paid-in capital 31,179,041 30,669,220 30,599,931 Accumulated deficit (49,800,829 ) (36,021,120 ) (35,273,181 ) Total Stockholders' Deficit (18,280,246 ) (5,010,358 ) (4,331,708 ) TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 6,382,988 $ 3,079,429 $ 3,234,619 CONSOLIDATED BALANCE SHEETS (Unaudited) As of June 30, 2016 ASSETS CURRENT ASSETS Cash and cash equivalents $ 12,205 Accounts receivable 62,924 Inventory 24,431 Other current assets — Total Current Assets 99,560 PROPERTY AND EQUIPMENT, NET 5,453 RIGHT-OF-USE ASSET — INTANGIBLE ASSETS, NET 3,359,885 OTHER NONCURRENT ASSETS 2,626 TOTAL ASSETS $ 3,467,524 LIABILITIES AND STOCKHOLDERS’ DEFICIT CURRENT LIABILITIES Accounts payable and accrued expenses $ 3,011,834 Accrued compensation and related liabilities 1,228,969 Accrued interest 633,173 Notes Payable 1,369,856 Convertible notes payable 697,000 Derivative liability — Total Current Liabilities 6,940,832 LONG-TERM LIABILITIES Accrued interest payable — Accrued return on non-controlling interest — Mortgage notes payable — Total Long-Term Liabilities — TOTAL LIABILITIES 6,940,832 STOCKHOLDERS’ DEFICIT Series A preferred stock 13 Common stock 341,529 Additional paid-in capital 30,564,371 Accumulated deficit (34,379,221 ) Accumulated other comprehensive income — Total Stockholders' Deficit (3,473,308 ) Noncontrolling interests — TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT $ 3,467,524 CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) For the three months ended June 30, 2019 2018 2017 Revenue $ — $ — $ 109,539 Operating Expenses General and Administrative 937,765 135,178 179,566 Amortization of intangible assets 61,306 61,306 61,306 Preliminary stage acquisition costs 82,693 — — Total Operating Expenses 1,081,764 196,484 240,872 Operating Loss (1,081,764 ) (196,484 ) (131,333 ) Other Income (Expense) Other Income (Expenses) — — 28,279 Interest expense, net (89,546 ) (80,632 ) (152,553 ) Gain on settlement of liabilities — — — Change in fair value derivative and finance — — — charges related to derivative liability 1,318,000 — — Other Income (Expense), Net 1,228,454 (80,632 ) (124,274 ) Net (Loss)/Income $ 149,690 $ (277,116 ) $ (255,607 ) Basic and diluted Loss per Common Share: Net Loss per Common Share $ (0.00 ) $ 0.00 $ (0.00 ) Basic and diluted Weighted-Average Common Shares Outstanding 341,546,009 341,529,434 341,529,434 CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) For the three months ended June 30, 2016 Revenue $ 79,583 Operating Expenses — General and Administrative 401,838 Other Operating — Total Operating Expenses 401,838 Operating Loss (322,255 ) Other Income (Expense) Other Income (Expense) 67,349 Interest expense, net (138,770 ) Gain on settlement of liabilities 537,612 Change in fair value derivative — Foreign currency transaction gain (loss) 106,563 Total Other Income (Expense), Net 572,753 Loss from Continuing Operations 250,498 Loss from Discontinued Operations — Net (Loss)/Income $ 250,498 Basic and diluted Loss per Common Share: Net Loss per Common Share $ (0.00 ) Basic and diluted Weighted-Average Common Shares Outstanding 341,529,434 CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) For the six months ended June 30, 2019 2018 2017 Revenue $ — $ — $ 159,873 Operating Expenses General and Administrative 1,065,342 261,842 396,434 Amortization of intangible assets 122,613 122,613 122,613 Preliminary stage acquisition costs 1,016,936 — — Total Operating Expenses 3,104,891 384,455 519,047 Operating Loss (3,104,891 ) (384,455 ) (359,174 ) Other Income (Expense) Other Income (Expense) — 425,000 28,279 Interest expense, net (180,075 ) (161,263 ) (229,856 ) Gain on settlement of liabilities — — — Change in fair value derivative and finance charges related to derivative liability (2,619,000 ) — — Other Income (Expense), Net (2,799,075 ) 263,737 (201,577 ) Net Loss $ (5,903,966 ) $ (120,718 ) $ (560,751 ) Basic and diluted Loss per Common Share: Net Loss per Common Share $ (0.02 ) $ (0.00 ) $ (0.00 ) Basic and diluted Weighted-Average Common Shares Outstanding 341,546,009 341,529,434 341,529,434 CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) For the six months ended June 30, 2016 Revenue $ 201,230 Operating Expenses General and Administrative 855,898 Other operating — Total Operating Expenses 855,899 Operating Loss (654,668 ) Other Income (Expense) Other Income (Expense) 54,528 Interest expense, net (212,287 ) Gain on settlement of liabilities 537,612 Change in fair value derivative — Foreign currency transaction gain (loss) 105,563 Total Other Income (Expense), Net 486,416 Net Loss $ (168,252 ) Basic and diluted Loss per Common Share: Net Loss per Common Share $ (0.00 ) Basic and diluted Weighted-Average Common Shares Outstanding 341,149,556 Statement of Comprehensive Income Net Loss $ (168,252 ) Other comprehensive loss-foreign currency translation adjustment — Comprehensive Loss $ (168,252 ) CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) For the three months ended June 30, 2019 2018 2017 Operating Activities: Net loss $ 146,690 $ (277,116 ) $ (255,607 ) Adjustments to reconcile net loss to net cash used in operating activities: Gain on settlement of liabilities — — — Share-based compensation 460,395 59,041 — Depreciation and amortization 61,307 61,306 61,306 Change in fair value of derivative liability (1,318,000 ) — — Changes in operating assets and liabilities: Accounts receivable — — (25,081 ) Inventory — — — Accounts payable and accrued expenses 23,444 (46,189 ) 42,429 Accrued compensation and related liabilities — (2,549 ) 26,944 Interest payable 90,529 80,631 151,743 Other Operating Activities — — — Net Cash Used in Operating Activities (535,635 ) (124,876 ) 1,734 Investing Activities: Pre-acquisition costs and deposits (1,255,382 ) — — Cash received from derivative forward contract — — — Net Cash Used in Investing Activities (1,255,382 ) — — Financing Activities: Debt issuance costs (100,000 ) — — Proceeds from exercise of stock options — — — Net Cash Used in Financing Activities (100,000 ) — — Net change in Cash and Cash Equivalents (1,891,017 ) (124,876 ) 1,734 Cash and Cash Equivalents at Beginning of Period 4,166,517 285,890 63,244 Cash and Cash Equivalents at End of Period $ 2,275,500 $ 161,014 $ 64,978 CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) For the three months ended June 30, 2016 Operating Activities: Net loss $ 250,498 Adjustments to reconcile net loss to net cash used in operating activities: Foreign currency transaction gain — Gain on settlement of liabilities (255,752 ) Share-based compensation 4,606 Write-down of long lived assets — Depreciation and amortization 62,933 Amortization of debt discount — Change in fair value of derivative (106,000 ) Changes in operating assets and liabilities: Accounts receivable (52,764 ) Inventory 1,490 Accounts payable and accrued expenses (179,963 ) Accrued compensation and related liabilities 104,566 Interest payable 178,144 Other Operating Activities — Other noncurrent assets — Other current assets 41,306 Net Cash Used in Operating Activities 49,063 Investing Activities: Plantation developments costs Net Cash Used in Investing Activities — Financing Activities: Proceeds from issuance of preferred membership in GCE Mexico I, LLC — Net Cash Provided by Financing Activities — Cash Flows of discontinued operations: Operating cash flows 64,257 Investing cash flows — Financing cash flows (including cash at year-end) — Net Cash flows from discontinued operations 64,257 Effect of exchange rate changes on cash (103,371 ) Net change in Cash and Cash Equivalents 9,949 Cash and Cash Equivalents at Beginning of Period 2,256 Cash and Cash Equivalents at End of Period $ 12,205 CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) For the six months ended June 30, 2019 2018 2017 Operating Activities: Net loss $ (5,903,966 ) $ (120,718 ) $ (560,751 ) Adjustments to reconcile net loss to net cash used in operating activities: Gain on settlement of liabilities — — — Share-based compensation 503,403 69,289 35,560 Depreciation and amortization 122,613 122,613 122,613 Change in fair value of derivative liability 2,619,000 — — Changes in operating assets and liabilities: Accounts receivable — — 87,173 Inventory — — — Accounts payable and accrued expenses 882,307 (72,616 ) 74,559 Accrued compensation and related liabilities (21 ) (2,549 ) 53,889 Interest payable 181,057 161,262 229,771 Other Operating Activities — — — Net Cash Used in Operating Activities (1,595,607 ) 157,281 42,814 Investing Activities: Pre-acquisition costs and deposits (1,255,382 ) — — Net Cash Used in Investing Activities (1,255,382 ) — — Financing Activities: Debt issuance costs (100,000 ) — — Proceeds from exercise of stock options — — — Net Cash Used in Financing Activities (100,000 ) — — Net change in Cash and Cash Equivalents (2,950,989 ) 157,281 42,814 Cash and Cash Equivalents at Beginning of Period 5,226,489 3,733 22,164 Cash and Cash Equivalents at End of Period $ 2,275,500 $ 161,014 $ 64,978 CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) For the six months ended June 30, 2016 Operating Activities: Net loss $ (168,252 ) Adjustments to reconcile net loss to net cash used in operating activities: Foreign currency transaction gain — Gain on settlement of liabilities (255,752 ) Share-based compensation 31,311 Depreciation and amortization 125,029 Amortization of debt discount — Change in fair value of derivative (106,000 ) Changes in operating assets and liabilities: Accounts receivable (52,764 ) Inventory 2,113 Accounts payable and accrued expenses (29,778 ) Accrued compensation and related liabilities 104,566 Interest payable 178,144 Other current assets 36,846 Other noncurrent assets — Net Cash Used in Operating Activities (134,538 ) Investing Activities: Plantation developments costs — Net Cash Used in Investing Activities — Financing Activities: Proceeds from issuance of preferred membership in GCE Mexico I, LLC — Net Cash Provided by Financing Activities — Cash Flows of discontinued operations: Operating cash flows 218,015 Investing cash flows — Financing cash flows (including cash at year-end) — Net Cash flows from discontinued operations 218,015 Effect of exchange rate changes on cash (105,976 ) Net change in Cash and Cash Equivalents (22,499 ) Cash and Cash Equivalents at Beginning of Period 34,704 Cash and Cash Equivalents at End of Period $ 12,205 CONSOLIDATED BALANCE SHEETS (Unaudited) As of September 30, 2019 2018 2017 ASSETS CURRENT ASSETS Cash and cash equivalents $ 217,214 $ 57,414 $ 70,996 Accounts receivable — 19,082 — Inventory 22,942 22,942 22,942 Total Current Assets 240,156 99,438 93,938 PROPERTY AND EQUIPMENT, NET 1,706 1,706 1,706 RIGHT-OF-USE ASSET 89,911 — — INTANGIBLE ASSETS, NET 2,562,899 2,808,125 3,053,352 DEBT ISSUANCE COSTS 250,000 — — PRE-ACQUISITION COSTS 1,861,481 — — DEPOSITS 1,005,253 5,253 5,253 TOTAL ASSETS $ 6,011,406 $ 2,914,522 $ 3,154,249 LIABILITIES AND STOCKHOLDERS' DEFICIT CURRENT LIABILITIES Accounts payable and accrued expenses $ 3,779,971 $ 2,832,289 $ 2,944,450 Accrued compensation and related liabilities 1,469,100 2,003,482 1,679,087 Accrued interest 1,643,998 1,291,782 1,008,717 Lease liabilities 90,083 — — Notes payable 1,369,856 1,369,856 1,369,856 Convertible notes payable 1,697,000 697,000 697,000 Derivative liability 14,130,000 — — Total Current Liabilities 24,180,008 8,194,409 7,699,110 LONG-TERM LIABILITIES Convertible notes payable — — — TOTAL LIABILITIES 24,180,008 8,194,409 7,699,110 STOCKHOLDERS' DEFICIT Series A preferred stock 13 13 13 Common stock 344,029 341,529 341,529 Additional paid-in capital 31,216,468 30,669,220 30,599,931 Accumulated deficit (49,729,112 ) (36,290,649 ) (35,486,334 ) Total Stockholders' Deficit (18,168,602 ) (5,279,887 ) (4544,861 ) TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 6,011,406 $ 2,914,522 $ 3,154,249 CONSOLIDATED BALANCE SHEETS (Unaudited) As of September 30, 2016 ASSETS CURRENT ASSETS Cash and cash equivalents $ 17,179 Accounts receivable 87,589 Inventory 23,686 Other current assets — Total Current Assets 128,454 PROPERTY AND EQUIPMENT, NET 3,812 RIGHT-OF-USE ASSET — INTANGIBLE ASSETS, NET 3,298,578 OTHER NONCURRENT ASSETS 5,253 TOTAL ASSETS $ 3,436,097 LIABILITIES AND STOCKHOLDERS' DEFICIT CURRENT LIABILITIES Accounts payable and accrued expenses $ 2,917,748 Accrued compensation and related liabilities 1,283,056 Accrued interest 685,474 Notes Payable 1,369,856 Convertible notes payable 697,000 Derivative liability — Total Current Liabilities 6,953,134 LONG-TERM LIABILITIES Accrued interest payable — Accrued return on non-controlling interest — Mortgage notes payable — Total Long-Term Liabilities 6,953,134 TOTAL LONG-TERM LIABILITIES 6,953,134 STOCKHOLDERS' DEFICIT Series A preferred stock 13 Common stock 341,529 Additional paid-in capital 30,564,371 Accumulated deficit (34,422,950 ) Accumulated other comprehensive income — Total Stockholders' Deficit (3,517,037 ) Noncontrolling interests — TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 3,436,097 CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) For the three months ended September 30, 2019 2018 2017 Revenue $ — $ — $ 179,288 Operating Expenses General and Administrative 126,509 127,591 289,158 Amortization of intangible assets 61,307 61,307 61,307 Preliminary stage acquisition costs 106,381 — — Total Operating Expenses 294,197 188,898 350,465 Operating Loss (294,197 ) (188,898 ) (171,177 ) Other Income (Expense) Other Income (Expense) — — — Interest expense, net (89,401 ) (80,631 ) (41,976 ) Gain on settlement of liabilities — — — Change in fair value derivative and finance — — — charges related to derivative liability 406,000 — — Other Income (Expense), Net 316,599 (80,631 ) (41,976 ) Net (Loss)/Income $ 22,402 (269,529 ) (213,153 ) Basic and diluted Loss per Common Share: Net Loss per Common Share (0.00 ) (0.00 ) (0.00 )         Basic and diluted Weighted-Average Common Shares Outstanding 341,529,434 341,529,434 341,529,434 CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) For the three months ended September 30, 2016 Revenue $ 117,087 Operating Expenses General and Administrative 150,299 Other Operating — Total Operating Expenses 150,299 Operating Loss (33,212 ) Other Income (Expense) Other Income (Expense) 3,635 Interest expense, net (14,152 ) Gain on settlement of liabilities — Change in fair value derivative — Foreign currency transaction gain (loss) — Total Other Income (Expense), Net (10,517 ) Loss from Continuing Operations (43,729 ) Loss from Discontinued Operations — Net Loss $ (43,729 ) Basic and diluted Loss per Common Share: Net Loss per Common Share $ (0.00 ) Basic and diluted Weighted-Average Common Shares Outstanding 341,529,454 Statement of Comprehensive Income Net Loss $ (43,729 ) Other comprehensive income (loss)-foreign currency translation adjustment — Comprehensive Loss $ (43,729 ) CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) For the nine months ended September 30, 2019 2018 2017 Revenue $ — $ — $ 339,161 Operating Expenses General and Administrative 2,048,954 389,433 685,592 Amortization of intangible assets 183,920 183,920 183,920 Preliminary stage acquisition costs 1,123,317 — — Total Operating Expenses 3,356,191 573,353 869,512 Operating Loss (3,356,191 ) (573,353 ) (530,351 ) Other Income (Expense) Other Income (Expense) — 425,000 28,279 Interest expense, net (269,476 ) (241,894 ) (271,832 ) Gain on settlement of liabilities — — — Change in fair value derivative and finance — — — charges related to derivative liability (2,213,000 ) — — Other Income (Expense), Net (2,482,476 ) (183,106 ) (243,553 ) Net Loss $ (5,838,667 ) $ (390,247 ) $ (773,904 ) Basic and diluted Loss per Common Share: Net Loss per Common Share $ (0.02 ) $ (0.00 ) $ (0.00 ) Basic and diluted Weighted-Average Common Shares Outstanding 342,208,921 341,529,434 341,529,434 CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) For the nine months ended September 30, 2016 Revenue $ 318,317 Operating Expenses General and Administrative 1,006,197 Other Operating — Total Operating Expenses 1,006,197 Operating Loss (687,880 ) Other Income (Expense) Other Income (Expense) 58,163 Interest expense, net (226,439 ) Gain on settlement of liabilities 537,612 Change in fair value derivative — Foreign currency transaction gain (loss) 106,563 Total Other Income (Expense), Net 475,899 Net Loss $ (211,981 ) Basic and diluted Loss per Common Share: Net Loss per Common Share $ (0.00 ) Basic and diluted Weighted-Average Common Shares Outstanding 341,529,454 Statement of Comprehensive Income Net Loss $ (211,981 ) Other comprehensive income (loss)-foreign currency translation adjustment — Comprehensive Loss $ (211,981 ) CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) For the three months ended September 30, 2019 2018 2017 Operating Activities: Net loss $ 22,402 $ (269,529 ) $ (213,153 ) Adjustments to reconcile net loss to net cash used in operating activities: Gain on settlement of liabilities — — — Share-based compensation 71,742 — — Depreciation and amortization 61,306 61,307 61,307 Change in fair value of derivative liability (406,000 ) — — Changes in operating assets and liabilities: Accounts receivable — — 25,081 Inventory — — — Accounts payable and accrued expenses (159,665 ) 23,990 64,667 Accrued compensation and related liabilities — — 26,944 Interest payable 90,528 80,632 41,171 Other Operating Activities — — — Net Cash Used in Operating Activities (319,687 ) (103,600 ) 6,018 Investing Activities: Pre-acquisition costs and deposits (1,606,099 ) — — Cash received from derivative forward contract — — — Net Cash Used in Investing Activities (1,606,099 ) — — Financing Activities: Debt issuance costs (150,000 ) — — Proceeds from exercise of stock options 17,500 — — Net Cash Used in Financing Activities 132,500 — — Net change in Cash and Cash Equivalents (2,058,286 ) (103,599 ) 6,018 Cash and Cash Equivalents at Beginning of Period 2,275,500 161,014 64,978 Cash and Cash Equivalents at End of Period $ 217,214 $ 57,415 $ 70,996 CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) For the three months ended September 30, 2016 Operating Activities: Net loss $ (43,729 ) Adjustments to reconcile net loss to net cash used in operating activities: Foreign currency transaction gain — Gain on settlement of liabilities — Share-based compensation — Write-down of long lived assets — Loss on disposal of fixed assets — Depreciation and amortization 62,947 Amortization of debt discount — Change in fair value of derivative — Changes in operating assets and liabilities: Accounts receivable (24,665 ) Inventory (745 ) Accounts payable and accrued expenses (94,086 ) Accrued compensation and related liabilities 54,087 Interest payable 52,301 Other Operating Activities — Other current assets (2,627 ) Other noncurrent assets — Net Cash Used in Operating Activities 4,974 Investing Activities: Plantation developments costs — Proceeds from sale of property and equipment — Net Cash Used in Investing Activities — Financing Activities: Proceeds from issuance of preferred membership in GCE Mexico I, LLC — Net Cash Provided by Financing Activities — Cash Flows of discontinued operations: Operating cash flows Investing cash flows — Financing cash flows (including cash at year-end) — Net Cash flows from discontinued operations — Effect of exchange rate changes on cash — Net Change in Cash and Cash Equivalents 4,974 Cash and Cash Equivalents at Beginning of Period 12,205 Cash and Cash Equivalents at End of Period $ 17,179 CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) For the nine months ended September 30, 2019 2018 2017 Operating Activities: Net loss $ (5,881,564 ) $ (390,247 ) $ (773,904 ) Adjustments to reconcile net loss to net cash used in operating activities: Gain on settlement of liabilities — — — Share-based compensation 575,145 69,289 35,560 Depreciation and amortization 183,919 183,920 183,920 Change in fair value of derivative liability 2,213,000 — — Changes in operating assets and liabilities: Accounts receivable — — 112,254 Inventory — — — Accounts payable and accrued expenses 722,642 (48,626 ) 139,226 Accrued compensation and related liabilities (21 ) (2,549 ) 80,833 Interest payable 271,585 241,894 270,943 Other Operating Activities — — — Net Cash Used in Operating Activities (1,915,294 ) 53,681 48,832 Investing Activities: Pre-acquisition costs and deposits (2,861,481 ) Net Cash Used in Investing Activities (2,861,481 ) — — Financing Activities: Debt issuance costs (250,000 ) Proceeds from exercise of stock options 17,500 — — Net Cash Used in Financing Activities (232,500 ) — — Net Change in Cash and Cash Equivalents (5,009,275 ) 53,681 48,832 Cash and Cash Equivalents at Beginning of Period 5,226,489 3,733 22,164 Cash and Cash Equivalents at End of Period $ 217,214 $ 57,414 $ 70,996 CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) For the nine months ended September 30, 2016 Operating Activities: Net loss $ (211,981 ) Adjustments to reconcile net loss to net cash used in operating activities: Foreign currency transaction gain — Gain on settlement of liabilities (255,752 ) Share-based compensation 31,311 Write-down of long-lived assets — Loss on disposal of fixed assets — Depreciation and amortization 187,976 Amortization of debt discount — Change in fair value of derivative (106,000 ) Changes in operating assets and liabilities: Accounts receivable (77,429 ) Inventory 2,858 Accounts payable and accrued expenses (123,864 ) Accrued compensation and related liabilities 158,653 Interest payable 230,445 Other current assets 34,219 Other noncurrent assets — Net Cash Used in Operating Activities (129,564 ) Investing Activities: Plantation developments costs — Proceeds from sale of property and equipment — Net Cash Used in Investing Activities — Financing Activities: Proceeds from issuance of preferred membership in GCE Mexico I, LLC Net Cash Provided by Financing Activities — Cash Flows of discontinued operations: Operating cash flows 218,015 Investing cash flows — Financing cash flows (including cash at year-end) — Net Cash flows from discontinued operations 218,015 Effect of exchange rate changes on cash (105,976 ) Net Change in Cash and Cash Equivalents (17,525 ) Cash and Cash Equivalents at Beginning of Period 34,704 Cash and Cash Equivalents at End of Period $ 17,179

ORGANIZATION AND SIGNIFICANT _4

ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)	3 Months Ended					12 Months Ended
	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Dec. 31, 2019
Accounting Policies [Abstract]
Beginning balance	$ 15,854,000	$ 11,917,000	$ 14,536,000	$ 14,130,000		$ 14,130,000
New contract/contract addition				4,000,000	15,114,000	4,000,000
(Gain) loss in fair value recognized in earnings	(1,318,000)	3,937,000	(406,000)	6,637,000	(3,197,000)	8,850,000
Ending balance	$ 14,536,000	$ 15,854,000	$ 11,917,000	$ 14,536,000	$ 14,130,000	$ 14,536,000

ORGANIZATION AND SIGNIFICANT _5

ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (Details 2) - shares	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Convertible Preferred Stock - Series B
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	11,818,181	11,818,181	11,818,181	11,818,181
Warrant
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount				3,083,332
Compensation Based Stock Options and Warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	199,027,315	137,427,315	52,586,692	84,782,003
Convertible notes and accrued interest
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	98,794,390	93,657,637	26,156,533	24,266,533

ORGANIZATION AND SIGNIFICANT _6

ORGANIZATION AND SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	1 Months Ended				12 Months Ended
	Jun. 30, 2020	May 31, 2020	Oct. 31, 2019	Oct. 31, 2018	Dec. 31, 2022	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Apr. 30, 2020
Capitalization of pre-acquisition costs						$ 5,800,000
Debt issuance cost				$ 9,100,000		500,000
Proceeds from financing				$ 6,000,000
Additional proceeds from financing			$ 4,000,000
Stock based compensation						$ 577,645	$ 68,289	$ 33,560	$ 33,311
Subsequent Event [Member]
Fixed payment obligation										$ 24,800,000
Repayment of debt	$ 4,500,000				$ 20,300,000
Bakersfield Refinery
Financing for retrofit		$ 365,000,000
Maximum | Field Equipment
Property, Plant and Equipment, Useful Life						15 years
Maximum | Office Equipment
Property, Plant and Equipment, Useful Life						5 years
Minimum | Field Equipment
Property, Plant and Equipment, Useful Life						5 years
Minimum | Office Equipment
Property, Plant and Equipment, Useful Life						3 years

BASIS OF PRESENTATION AND LIQ_2

BASIS OF PRESENTATION AND LIQUIDITY (Details Narrative) - USD ($)	3 Months Ended												6 Months Ended				9 Months Ended				12 Months Ended
	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2014
Notes to Financial Statements
Losses from continuing operations																					$ 11,800,000	$ 8,000,000	$ 1,200,000	$ 500,000
Accumulated deficit	$ 49,729,112	$ 49,800,829	$ 49,941,101	$ 36,290,649	$ 36,021,120	$ 35,744,004	$ 35,486,334	$ 35,273,181	$ 35,017,574	$ 34,422,950	$ 34,379,221	$ 34,629,719	$ 49,800,829	$ 36,021,120	$ 35,273,181	$ 34,379,221	$ 49,729,112	$ 36,290,649	$ 35,486,334	$ 34,422,950	55,682,264	43,890,445	35,900,402	34,712,430	$ 34,210,969
Operating losses	$ 294,197	$ 1,081,764	$ 2,023,127	$ 188,898	$ 196,484	$ 187,971	$ 171,177	$ 131,333	$ 227,842	$ 33,212	$ 322,255	$ (454,060)	$ 3,104,891	$ 384,455	$ 359,174	$ 654,668	$ 3,399,088	$ 573,353	$ 530,351	$ 687,880	4,932,640	2,056,717	888,138	935,291	1,608,056
Working capital deficit																					33,000,000
Stockholders' deficit																					$ 24,078,857	$ 12,879,683	$ 4,958,929	$ 3,806,517	$ 3,230,391	$ 8,220,435

PROPERTY AND EQUIPMENT (Details

PROPERTY AND EQUIPMENT (Details) - USD ($)	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015
Property and equipment, cost	$ 61,078				$ 71,906				$ 71,906				$ 71,906				$ 75,303
Less accumulated depreciation	61,078				70,200				70,200				69,736				67,435
Property and equipment, net		$ 1,706	$ 1,706	$ 1,706	1,706	$ 1,706	$ 1,706	$ 1,706	1,706	$ 1,706	$ 1,706	$ 1,706	2,170	$ 3,812	$ 5,453	$ 7,094	7,868
Office Equipment
Property and equipment, cost	61,078				61,601				61,601				61,601				64,729
Field Equipment
Property and equipment, cost					$ 10,305				$ 10,305				$ 10,305				$ 10,574

PROPERTY AND EQUIPMENT (Detai_2

PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 0	$ 0	$ 464	$ 2,301	$ 66,859

PATENT LICENSE FEES (Details)

PATENT LICENSE FEES (Details) - Patents [Member] - USD ($)	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Patent license fees	$ 4,187,902	$ 4,186,289	$ 4,168,841	$ 4,168,841	$ 4,168,841
Less accumulated amortization	(1,686,310)	(1,439,471)	(1,176,796)	(931,569)	(686,343)
Intangible Assets, Net	$ 2,501,592	$ 2,746,818	$ 2,992,045	$ 3,237,272	$ 3,482,498

PATENT LICENSE FEES (Details Na

PATENT LICENSE FEES (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2013
Notes to Financial Statements
Expected useful life, patent						17 years
Amortization of intangible assets	$ 245,000	$ 245,000	$ 245,000	$ 245,000	$ 245,000

DEBT (Details Narrative)

DEBT (Details Narrative) - USD ($)	3 Months Ended												6 Months Ended				9 Months Ended				12 Months Ended					25 Months Ended
	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Oct. 16, 2020	Oct. 16, 2018
Accrued interest expense	$ 89,401	$ 89,546	$ 90,529	$ 80,631	$ 80,632	$ 80,631	$ 41,976	$ 152,553	$ 77,302	$ 14,152	$ 138,770	$ 73,517	$ 180,075	$ 161,263	$ 229,856	$ 212,287	$ 269,476	$ 241,894	$ 271,832	$ 226,439	$ 439,479	$ 441,326	$ 312,113	$ 283,049	$ 334,618
Accrued interest payable	$ 1,643,998	$ 1,553,470	$ 1,462,941	$ 1,291,782	$ 1,211,150	$ 1,130,519	$ 1,008,717	$ 967,545	$ 815,802	$ 685,474	$ 633,173	$ 528,573	$ 1,553,470	$ 1,211,150	$ 967,545	$ 633,173	$ 1,643,998	$ 1,291,782	$ 1,008,717	$ 685,474	1,734,527	1,372,413	$ 1,049,888	$ 737,774	$ 455,029
Chief Executive Officer and President
Accrued salary and bonus																											$ 1,000,000
Convertible note payable																					700,000						$ 1,000,000
Interest rate																										5.00%
Maturity date																										Oct. 15, 2020
Accrued interest expense																					50,000	10,411
Accrued interest payable																					$ 60,411	$ 10,411
Debt conversion price																											$ 0.0154
Debt conversion, description																					The Company has several notes that are convertible into the Company or the Company’s subsidiaries shares at different prices: from $0.03 per share into the parent company’s stock and up to $1.48 per share into a subsidiary’s common stock
Interest rate, description																					These notes are past due their original maturity date and they continue to accrue interest at varying rates, from 8% to 10%.
Derecognized outstanding liabilities																					$ 2,400,000

STOCKHOLDERS' EQUITY (Details)

STOCKHOLDERS' EQUITY (Details) - USD ($)	Nov. 06, 2007	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Stock Options Exercised		2,500,000
Two Investors | Series B Convertible Preferred Stock
Preferres stock shares sold	13,000
Proceeds from sale of stock	$ 1,300,000
Offering cost	$ 9,265
Sale of stock price per share	$ 100
Conversion price per share	$ 0.11

STOCK OPTIONS AND WARRANTS (Det

STOCK OPTIONS AND WARRANTS (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Text Block [Abstract]
Options, Outstanding, Beginning Balance	137,427,315	52,586,692	84,782,003	93,208,997
Options, Granted	66,500,000	118,750,000	3,500,000	7,300,000
Options, Exercised	(2,500,000)
Options, Forfeited		(24,959,377)	(7,500,000)	(4,800,000)
Options, Expired	(2,400,000)	(8,950,000)	(28,195,311)	(10,926,994)
Options, Outstanding, Ending Balance	199,027,315	137,427,315	52,586,692	84,782,003	93,208,997
Options Exercisable	184,964,315
Options, Outstanding, Weighted Average Exercise Price, Beginning Balance	$ 0.014	$ 0.013	$ 0.015	$ 0.015
Options, Granted, Weighted Average Exercise Price	0.019	0.015	0.004	0.002
Options, Exercise, Weighted Average Exercise Price	0.006
Options, Forfeited, Weighted Average Exercise Price		0.015	0.006	0.024
Options, Expired, Weighted Average Exercise Price	0.01	0.022	0.018	0.008
Options, Outstanding, Weighted Average Exercise Price, Ending Balance	0.016	$ 0.014	$ 0.013	$ 0.015	$ 0.015
Options Exercisable, Exercise Price	$ .16
Options, Outstanding, Weighted Average Remaining Contractual Term	3 years 7 months 6 days	4 years 4 months 24 days	1 year 7 months 6 days	1 year 8 months 12 days	2 years 2 months 12 days
Options, Vested and Exercisable, Weighted Average Remaining Contractual Life	3 years 7 months 6 days
Options, Outstanding, Intrinsic Value, Beginning Balance	$ 28,260	$ 600
Options, Outstanding, Intrinsic Value, Ending Balance	14,360,463	$ 28,260	$ 600
Options Exercisable, Intrinsic Value	$ 13,468,745

STOCK OPTIONS AND WARRANTS (D_2

STOCK OPTIONS AND WARRANTS (Details 2) - USD ($)		12 Months Ended
		Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016
Expected Term (in Years)					3 years 9 months
Volatility		123.00%	123.00%
Risk free Rate		2.80%	2.80%
Dividend Yield		0.00%	0.00%	0.00%	0.00%
Suboptimal Exercise Factor	[1]	1.30%	1.30%	0.00%	0.00%
Exit Rate Pre-Vesting	[2]	0.00%	0.00%	0.00%	0.00%
Exit Rate Post Vesting	[3]	0.00%	0.00%	0.00%	0.00%
Aggregate Grant Date Fair value		$ 326,644	$ 396,074	$ 12,737	$ 19,038
Minimum
Expected Term (in Years)		2 years	2 years	3 years
Volatility				175.00%	142.00%
Risk free Rate				1.90%	1.40%
Maximum
Expected Term (in Years)		5 years	5 years	3 years 9 months
Volatility				189.00%	156.00%
Risk free Rate				2.00%	2.00%
[1]	The suboptimal exercise factor estimates the value realized by the holder upon exercise of the option and the estimated point at which an option holder would exercise an in-the-money option. The Company estimated the suboptimal factor based on the holder realizing a pre-tax profit of $500,000. Used for lattice model purposes only.
[2]	Assumed forfeiture rate for market condition option awards prior to vesting. Used for lattice model purposes only.
[3]	Assumed expiration or forfeiture rate for market condition option awards after vesting. Used for lattice model purposes only.

STOCK OPTIONS AND WARRANTS (D_3

STOCK OPTIONS AND WARRANTS (Details Narrative) - USD ($)

May 07, 2020

Jul. 02, 2019

Jan. 15, 2019

Dec. 14, 2018

Jul. 02, 2018

Nov. 02, 2017

Jul. 02, 2017

Dec. 14, 2016

Jul. 02, 2016

Jun. 21, 2019

Oct. 16, 2018

Sep. 17, 2018

Jan. 29, 2018

May 26, 2016

Dec. 31, 2020

Dec. 31, 2019

Dec. 31, 2018

Dec. 31, 2017

Dec. 31, 2016

Options, Granted

66,500,000

118,750,000

3,500,000

7,300,000

Share-based Compensation

$ 577,645

$ 69,289

$ 35,560

$ 31,311

Compensation Cost Not yet Recognized, Stock Based Payments

$ 106,000

Compensation Cost Not yet Recognized, Period for Recognition

2 years 2 months 30 days

Warrants, granted

3,083,332

Subsequent Event [Member]

Non-transferable warrant issued

20,000,000

Warrant expiration date

Jun. 1, 2021

Executive Vice President

Non-qualified options, Granted

50,000,000

Options expire term

5 years

Executive Vice President | Subsequent Event [Member]

Non-qualified options, Granted

110,000,000

Options expire term

5 years

2010 Equity Incentive Plan | Chairman

Options, Granted

500,000

Non-qualified options, Granted

500,000

500,000

500,000

Options expire term

5 years

5 years

5 years

5 years

Exercise price

$ 0.065

$ 0.0056

$ 0.015

$ 0.003

2010 Equity Incentive Plan | Employees and Consultants

Options, Granted

2,500,000

3,000,000

2,300,000

Non-qualified options, Granted

500,000

500,000

1,000,000

Options expire term

5 years

5 years

5 years

Exercise price

$ 0.0022

$ 0.0017

$ 0.003

2010 Equity Incentive Plan | Executive Vice President

Non-qualified options, Granted

50,000,000

5,000,000

Options expire term

5 years

5 years

Exercise price

$ 0.02

$ 0.035

2010 Equity Incentive Plan | Consultant

Non-qualified options, Granted

2,500,000

Options expire term

5 years

Exercise price

$ 0.007

2010 Equity Incentive Plan | Chief Executive Officer

Non-qualified options, Granted

110,000,000

Options expire term

5 years

Exercise price

$ 0.0154

2010 Equity Incentive Plan | Board1Member

Non-qualified options, Granted

500,000

Options expire term

5 years

Exercise price

$ 0.08

2010 Equity Incentive Plan | Board member

Non-qualified options, Granted

500,000

Options expire term

5 years

Exercise price

$ 0.08

2010 Equity Incentive Plan | Attorneys

Non-qualified options, Granted

750,000

Options expire term

5 years

Exercise price

$ 0.0056

2010 Equity Incentive Plan | Related party

Options, Granted

110,000,000

50,000,000

INCOME TAXES (Details)

INCOME TAXES (Details) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Current:
Federal	$ (265,000)	$ (418,000)	$ (127,000)	$ 110,000	$ (319,000)
State	(123,000)	(193,000)	(36,000)	31,000
Deferred:
Federal	(1,992,000)	(1,111,000)	(241,000)	129,000	140,000
State	(920,000)	(513,000)	(69,000)	37,000
Change in Valuation Allowance	3,300,000	2,235,000	473,000	(307,000)	179,000
Provision for income taxes

INCOME TAXES (Details 2)

INCOME TAXES (Details 2)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Income Tax Disclosure [Abstract]
Federal statutory rate	21.00%	21.00%	21.00%	34.00%	34.00%
State, net of federal tax benefit	6.98%	6.98%	6.98%	5.83%	5.83%
Change in valuation allowance	(28.00%)	(28.00%)	(28.00%)	(40.00%)	(40.00%)
Effective tax rate

INCOME TAXES (Details 3)

INCOME TAXES (Details 3) - USD ($)	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Income Tax Disclosure [Abstract]
Deferred tax assets:	$ 14,563,000	$ 11,263,000	$ 9,028,000	$ 8,555,000	$ 8,862,000
Less: Valuation Allowance	(14,563,000)	(11,263,000)	(9,028,000)	(8,555,000)	(8,862,000)
Net deferred income taxes

INCOME TAXES (Details 4)

INCOME TAXES (Details 4) - USD ($)	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Income Tax Disclosure [Abstract]
Net operating losses	$ 8,530,000	$ 8,140,000	$ 7,529,000	$ 7,366,000	$ 7,507,000
Share based compensation	269,000	107,000	87,000	73,000	483,000
Accrued payroll	1,631,000	1,359,000	1,412,000	1,116,000	830,000
Impairment					42,000
Derivative Liability	4,132,000	1,656,000
Total deferred tax assets	14,562,000	11,262,000	9,028,000	8,555,000	8,862,000
Less: Valuation allowance	(14,562,000)	(11,262,000)	(9,028,000)	(8,555,000)	(8,862,000)
Net deferred income taxes

INCOME TAXES (Details 5)

INCOME TAXES (Details 5) - USD ($)	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Income Tax Disclosure [Abstract]
Net operating losses	$ 21,152,000	$ 19,765,000	$ 17,579,000	$ 17,169,000	$ 17,523,343

INCOME TAXES (Details Narrative

INCOME TAXES (Details Narrative)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Text Block [Abstract]
Combined deferred income tax rate	28.00%	28.00%	40.00%	40.00%
Federal statutory rate	21.00%	21.00%	21.00%	34.00%	34.00%

COMMITMENTS AND CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES (Details)	Dec. 31, 2019USD ($)
2020	$ 34,000
2021	35,000
2022	20,000
Lease Liability	89,000
Operating Lease Obligations [Member]
2020	29,000
2021	32,000
2022	19,000
Lease Liability	80,000
Discount [Member]
2020	5,000
2021	3,000
2022	1,000
Lease Liability	$ 9,000

COMMITMENTS AND CONTINGENCIES_3

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)

Sep. 10, 2020

May 07, 2020

May 02, 2019

Jan. 15, 2019

Oct. 16, 2018

Jul. 31, 2022

Jul. 31, 2021

Dec. 31, 2019

Dec. 31, 2018

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2014

Jul. 31, 2020

Options, Granted, Weighted Average Exercise Price

$ 0.019

$ 0.015

$ 0.004

$ 0.002

Lease expiration term

Jul. 31, 2022

Subsequent Event [Member]

Rent Expense

$ 3,024

$ 2,936

$ 2,851

Options, Granted

7,095,000

Executive Vice President

Options, Granted, Weighted Average Exercise Price

$ 0.02

Base Salary Amount

$ 310,000

Non-qualified options, Granted

50,000,000

Options expire term

5 years

Executive Vice President | Share-based Payment Arrangement, Tranche Two [Member]

Option vest

$ 15,000,000

Executive Vice President | Share-based Payment Arrangement, Tranche One [Member]

Option vest

7,000,000

Executive Vice President | Share-based Payment Arrangement, Tranche Three [Member]

Option vest

$ 25,000,000

Executive Vice President | Subsequent Event [Member]

Options, Granted, Weighted Average Exercise Price

$ 0.0154

Base Salary Amount

$ 350,000

Non-qualified options, Granted

110,000,000

Options expire term

5 years

Options exercise, description

Under the Option, Mr. Palmer vests, and can exercise the Option, with respect to 30,000,000 shares when the Company’s market capitalization first reaches $7 million, another 40,000,000 shares vest under the Option when the Company’s market capitalization reaches $15 million, and 40,000,000 shares vest when the Company’s market capitalization first reaches $25 million

Chief Executive Officer

Options, Granted

16,959,377

Options, Granted, Weighted Average Exercise Price

$ 0.0041

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights

25% vesting immediatly and the balance vesting in equal amounts over the next 48 months.

Base Salary Amount

$ 300,000

$ 250,000

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - USD ($)

Sep. 10, 2020

May 07, 2020

May 04, 2020

Apr. 30, 2020

Dec. 31, 2020

Dec. 31, 2019

Dec. 31, 2018

Dec. 31, 2017

Dec. 31, 2016

Dec. 31, 2014

Oct. 16, 2020

Apr. 10, 2020

Shares issued upon exercise of options

2,500,000

Subsequent Event [Member]

Options granted

7,095,000

Senior Lenders | Subsequent Event [Member]

Proceeds from senior secured loan

$ 300,000,000

Interest rate

12.50%

Mezzanine lenders | Subsequent Event [Member]

Proceeds from senior secured loan

$ 65,000,000

Interest rate

15.00%

Maturity date

Nov. 30, 2027

Executive Vice President | Subsequent Event [Member]

Annual base salary

$ 310,000

Chief Executive Officer

Options granted

16,959,377

Chief Executive Officer | Subsequent Event [Member]

Annual base salary

350,000

Shares issued upon exercise of options

5,542,857

Consultant | Subsequent Event [Member]

Shares issued upon exercise of options

7,677,315

Attorneys | Subsequent Event [Member]

Shares issued upon exercise of options

750,000

Chief Executive Officer and President

Interest rate

5.00%

Maturity date

Oct. 15, 2020

2020 Equity Incentive Plan | Subsequent Event [Member]

Shares reserve for future issuance

20,000,000

Bakersfield Renewable Fuels | Subsequent Event [Member]

Purchase price of outstanding equity interests

40,000,000

Plaintiffs value

$ 6,700,000

ARB, Inc. | Subsequent Event [Member]

Services fees

$ 201,400,000

QUARTERLY FINANCIAL DATA (Una_3

QUARTERLY FINANCIAL DATA (Unaudited) (Details) - USD ($)	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2017	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Dec. 31, 2016	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Dec. 31, 2015
CURRENT ASSETS
Cash and cash equivalents	$ 457,331	$ 217,214	$ 2,275,500	$ 4,166,517	$ 5,226,489	$ 57,414	$ 161,014	$ 285,890	$ 3,733	$ 70,996	$ 64,978	$ 63,244	$ 22,164	$ 17,179	$ 12,205	$ 2,256	$ 34,704
Accounts receivable						19,082	19,082	19,082	19,082		25,081		112,254	87,589	62,924	13,595	10,160
Inventory	22,942	22,942	22,942	22,942	22,941	22,942	22,942	22,942	22,942	22,942	22,942	22,942	22,942	23,686	24,431	25,921	26,544
Other current assets																100,149	36,846
Total Current Assets	480,273	240,156	2,298,442	4,189,459	5,249,430	99,438	203,038	327,914	45,757	93,938	113,001	86,186	157,360	128,454	99,560	141,921	326,269
PROPERTY AND EQUIPMENT, NET		1,706	1,706	1,706	1,706	1,706	1,706	1,706	1,706	1,706	1,706	1,706	2,170	3,812	5,453	7,094	7,868
RIGHT-OF-USE ASSET	82,450	89,911	98,000	104,000
INTANGIBLE ASSETS, NET	2,501,592	2,562,899	2,624,205	2,685,512	2,746,818	2,808,125	2,869,432	2,930,738	2,992,045	3,053,352	3,114,659	3,175,965	3,237,272	3,298,578	3,359,885	3,421,191	3,482,498
DEBT ISSUANCE COSTS	500,000	250,000	100,000
PRE-ACQUISITION COSTS	2,588,441	1,861,481	755,382
DEPOSITS	3,253,253	1,005,253	505,253	5,253	5,253	5,253	5,253	5,253	5,253	5,253	5,253	5,253
OTHER NONCURRENT ASSETS													5,254	5,253	2,626	2,626	2,626
TOTAL ASSETS	9,406,009	6,011,406	6,382,988	6,985,930	8,003,207	2,914,522	3,079,429	3,265,611	3,044,761	3,154,249	3,234,619	3,269,110	3,402,056	3,436,097	3,467,524	3,572,832	3,819,261
CURRENT LIABILITIES
Accounts payable and accrued expenses	1,778,434	3,779,971	3,939,808	3,916,364	3,057,500	2,832,289	2,808,299	2,854,488	2,880,915	2,944,450	2,879,783	2,837,354	2,805,689	2,917,748	3,011,834	3,060,695	3,041,612
Accrued compensation and related liabilities	2,055,167	1,469,100	1,469,100	1,469,100	1,469,121	2,003,482	2,003,482	2,006,031	2,006,031	1,679,087	1,652,143	1,625,199	1,598,254	1,283,056	1,228,969	1,435,216	1,380,155
Accrued interest	1,734,527	1,643,998	1,553,470	1,462,941	1,372,413	1,291,782	1,211,150	1,130,519	1,049,888	1,008,717	967,545	815,802	737,774	685,474	633,173	528,573	455,029
Lease liabilities	82,882	90,083	98,000	104,000
Notes payable	1,369,856	1,369,856	1,369,856	1,369,856	1,369,856	1,369,856	1,369,856	1,369,856	1,369,856	1,369,856	1,369,856	1,369,856	1,369,856	1,369,856	1,369,856	1,369,856	1,369,856
Convertible notes payable	1,697,000	1,697,000	697,000	697,000	697,000	697,000	697,000	697,000	697,000	697,000	697,000	697,000	697,000	697,000	697,000	697,000	697,000
Derivative Liability	24,767,000	14,130,000	14,536,000	15,854,000	11,917,000											106,000	106,000
Total Current Liabilities	33,484,866	24,180,008	23,663,234	24,873,261	19,882,890	8,194,409	8,089,787	8,057,894	8,003,690	7,699,110	7,566,327	7,345,211	7,208,573	6,953,134	6,940,832	7,197,340	7,049,652
LONG-TERM LIABILITIES
Accrued interest payable
Accrued return on noncontrolling interest
Mortgage notes payable
Convertible notes payable			1,000,000	1,000,000	1,000,000
Total Non Current Liabilities														6,953,134
TOTAL LIABILITIES	33,484,866	24,180,008	24,663,234	25,873,261	20,882,890	8,194,409	8,089,787	8,057,894	8,003,690	7,699,110	7,566,327	7,345,211	7,208,573	6,953,134	6,940,832	7,197,340	7,049,652
STOCKHOLDERS' DEFICIT
Preferred stock	13	13	13	13	13	13	13	13	13	13	13	13	13	13	13	13	13
Common stock	344,029	344,029	341,529	341,529	341,529	341,529	341,529	341,529	341,529	341,529	341,529	341,529	341,529	341,529	341,529	341,405	341,529
Additional paid-in capital	31,259,365	31,216,468	31,179,041	30,712,228	30,669,220	30,669,220	30,669,220	30,610,179	30,599,931	30,599,931	30,599,931	30,599,931	30,564,371	30,564,371	30,564,371	30,559,890	30,533,060
Accumulated deficit	(55,682,264)	(49,729,112)	(49,800,829)	(49,941,101)	(43,890,445)	(36,290,649)	(36,021,120)	(35,744,004)	(35,900,402)	(35,486,334)	(35,273,181)	(35,017,574)	(34,712,430)	(34,422,950)	(34,379,221)	(34,629,719)	(34,210,969)
Accumulated other comprehensive loss																103,903	105,976
Total Stockholders' Deficit	(24,078,857)	(18,168,602)	(18,280,246)	(18,887,331)	(12,879,683)	(5,279,887)	(5,010,358)	(4,792,283)	(4,958,929)	(4,544,861)	(4,331,708)	(4,076,101)	(3,806,517)	(3,517,037)	(3,473,308)	(3,624,508)	(3,230,391)
Noncontrolling interests
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 9,406,009	$ 6,011,406	$ 6,382,988	$ 6,985,930	$ 8,003,207	$ 2,914,522	$ 3,079,429	$ 3,265,611	$ 3,044,761	$ 3,154,249	$ 3,234,619	$ 3,269,110	$ 3,402,056	$ 3,436,097	$ 3,467,524	$ 3,572,832	$ 3,819,261

QUARTERLY FINANCIAL DATA (Una_4

QUARTERLY FINANCIAL DATA (Unaudited) (Details 2) - USD ($)	3 Months Ended												6 Months Ended				9 Months Ended				12 Months Ended
	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Disclosure Quarterly Financial Data Unaudited Details 2Abstract
Revenue							$ 179,288	$ 109,539	$ 50,334	$ 117,087	$ 79,583	$ 121,647			$ 159,873	$ 201,230			$ 339,161	$ 318,317			$ 369,702	$ 656,500	$ 537,807
Operating Expenses
General and administrative	126,509	937,765	1,027,577	127,591	135,178	126,664	289,158	179,566	216,869	150,299	401,838	454,060	1,065,342	261,842	396,434	855,898	2,091,851	389,433	685,592	1,006,197	3,061,580	1,282,037	1,012,614	1,587,966	1,707,496
Amortization of intangible assets	61,307	61,306	61,307	61,307	61,306	61,307	61,307	61,306	61,307				122,613	122,613	122,613		183,920	183,920	183,920		245,226	245,226	245,226
Prelliminary stage acquisition costs	106,381	82,693	934,243										1,016,936				1,123,317				1,625,834	529,454
Other Operating																								3,825	438,367
Total Operating Expenses	294,197	1,081,764	2,023,127	188,898	196,484	187,971	350,465	240,872	278,176	150,299	401,838		3,104,891	384,455	519,047	855,899	3,399,088	573,353	869,512	1,006,197	4,932,640	2,056,717	1,257,840	1,591,791	2,145,863
Operating Loss	(294,197)	(1,081,764)	(2,023,127)	(188,898)	(196,484)	(187,971)	(171,177)	(131,333)	(227,842)	(33,212)	(322,255)	454,060	(3,104,891)	(384,455)	(359,174)	(654,668)	(3,399,088)	(573,353)	(530,351)	(687,880)	(4,932,640)	(2,056,717)	(888,138)	(935,291)	(1,608,056)
Other Income (Expenses)
Other Income (Expenses), Net						425,000		28,279		3,635	67,349			425,000	28,279	54,528		425,000	28,279	58,163		425,000	12,279	72,704	10
Interest expense, net	(89,401)	(89,546)	(90,529)	(80,631)	(80,632)	(80,631)	(41,976)	(152,553)	(77,302)	(14,152)	(138,770)	(73,517)	(180,075)	(161,263)	(229,856)	(212,287)	(269,476)	(241,894)	(271,832)	(226,439)	(439,479)	(441,326)	(312,113)	(283,049)	(334,618)
Gain on settlement of liabilities											255,752					255,752				255,752	2,430,300			537,612	376,157
Change in fair value derivative and finance charges related to derivative liability													(2,619,000)								(8,850,000)	(5,917,000)
Change in fair value of derivative	(406,000)	(1,318,000)	3,397,000			344,369					(106,000)		2,619,000			(106,000)	2,213,000			(106,000)					(6,500)
Foreign currency transaction gain (loss)											106,563					105,563				106,563				106,563	(405)
Other Income (Expense), Net	316,599	1,228,454	(4,027,529)	(80,631)	(80,632)		(41,976)	(124,274)	(77,302)	(10,517)	572,753	(86,337)	(2,799,075)	263,737	(201,577)	486,416	(2,482,476)	(183,106)	(243,553)	475,899	(6,859,179)	(5,933,326)	(299,834)	433,830	34,644
LOSS FROM CONTINUING OPERATIONS										(43,729)	250,498													(501,461)	(1,573,412)
LOSS FROM DISCONTINUED OPERATIONS																									(7,444,940)
NET LOSS	$ 22,402	$ 146,690	$ (6,050,656)	$ (269,529)	$ (277,116)	$ 156,398	$ (213,153)	$ (255,607)	$ (305,144)	$ (43,729)	$ 250,498	$ (418,750)	$ (5,903,966)	$ (120,718)	$ (560,751)	$ (168,252)	$ (5,881,564)	$ (390,247)	$ (773,904)	$ (211,981)	$ (11,791,819)	$ (7,990,043)	$ (1,187,972)	$ (501,461)	$ (9,018,352)
BASIC AND DILUTED LOSS PER COMMON SHARE:
Net Loss per Common Share	$ 0	$ 0	$ (0.02)	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0	$ 0		$ (0.02)	$ 0	$ 0	$ 0	$ (0.02)	$ 0	$ 0	$ 0	$ (0.03)	$ (0.02)	$ 0	$ 0	$ 0
BASIC AND DILUTED WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING	341,529,434	341,546,009	341,529,434	341,529,434	341,529,434	341,529,434	341,529,434	341,529,434	341,529,434	341,529,454	341,529,434		341,546,009	341,529,434	341,529,434	341,149,556	342,208,921	341,529,434	341,529,434	341,529,454	342,789,708	341,529,434	341,529,434	341,529,434	341,529,434

QUARTERLY FINANCIAL DATA (Una_5

QUARTERLY FINANCIAL DATA (Unaudited) (Details 3) - USD ($)	3 Months Ended												6 Months Ended				9 Months Ended				12 Months Ended
	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Disclosure Quarterly Financial Data Unaudited Details 3Abstract
Net Loss	$ 22,402	$ 146,690	$ (6,050,656)	$ (269,529)	$ (277,116)	$ 156,398	$ (213,153)	$ (255,607)	$ (305,144)	$ (43,729)	$ 250,498	$ (418,750)	$ (5,903,966)	$ (120,718)	$ (560,751)	$ (168,252)	$ (5,881,564)	$ (390,247)	$ (773,904)	$ (211,981)	$ (11,791,819)	$ (7,990,043)	$ (1,187,972)	$ (501,461)	$ (9,018,352)
Foreign currency translation adjustment																									(1,150,651)
Comprehensive Income (Loss)										$ (30,402)						$ (168,252)				$ (211,981)	$ (11,791,819)	$ (7,990,043)	$ (1,187,972)	$ (607,437)	$ (10,169,003)

QUARTERLY FINANCIAL DATA (Una_6

QUARTERLY FINANCIAL DATA (Unaudited) (Details 4) - USD ($)	3 Months Ended												6 Months Ended				9 Months Ended				12 Months Ended
	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Sep. 30, 2017	Jun. 30, 2017	Mar. 31, 2017	Sep. 30, 2016	Jun. 30, 2016	Mar. 31, 2016	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2017	Jun. 30, 2016	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2017	Sep. 30, 2016	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015
Operating Activities
Net Loss	$ 22,402	$ 146,690	$ (6,050,656)	$ (269,529)	$ (277,116)	$ 156,398	$ (213,153)	$ (255,607)	$ (305,144)	$ (43,729)	$ 250,498	$ (418,750)	$ (5,903,966)	$ (120,718)	$ (560,751)	$ (168,252)	$ (5,881,564)	$ (390,247)	$ (773,904)	$ (211,981)	$ (11,791,819)	$ (7,990,043)	$ (1,187,972)	$ (501,461)	$ (9,018,352)
Adjustments to reconcile net loss to net cash used in operating activities:
Foreign currency transaction gain																								(105,976)
Gain on settlement of liabilities											(255,752)					(255,752)				(255,752)	(2,430,300)			(537,612)	(376,157)
Share-based compensation	71,742	460,395	43,008		59,041	10,248			35,560		4,606	26,705	503,403	69,289	35,560	31,311	575,145	69,289	35,560	31,311	577,645	69,289	35,560	31,311	133,172
Write down of long lived assets																									438,320
Loss on disposal of fixed assets
Depreciation and amortization	61,306	61,307	61,306	61,307	61,306	61,307	61,307	61,306	61,307	62,947	62,933	62,096	122,613	122,613	122,613	125,029	183,919	183,920	183,920	187,976	246,932	245,227	245,691	250,924	312,085
Amortization of debt discount
Change in fair value of derivative	(406,000)	(1,318,000)	3,397,000			344,369					(106,000)		2,619,000			(106,000)	2,213,000			(106,000)					(6,500)
Changes in operating assets and liabilities:
Accounts receivable							25,081	(25,081)	112,254	(24,665)	(52,764)				87,173	(52,764)			112,254	(77,429)		19,083	93,172	(102,094)	1,012,977
Inventory										(745)	1,490	623				2,113				2,858				3,602	1,239
Other current assets										(2,627)	41,306	(4,460)				36,846								36,846	(15,665)
Accounts payable and accrued expenses	(159,665)	23,444	858,863	23,990	(46,189)	(26,427)	64,667	42,429	32,130	(94,086)	(179,963)	150,185	882,307	(72,616)	74,559	(29,778)	722,642	(48,626)	139,226	(123,864)	1,151,234	176,585	75,227	45,937	341,741
Accrued compensation and related liabilities			(21)		(2,549)		26,944	26,944	26,944	54,087	104,566		(21)	(2,549)	53,889	104,566	(21)	(2,549)	80,833	158,653	586,046	463,090	407,777	473,851
Interest payable	90,528	90,529	90,528	80,632	80,631	80,631	41,171	151,743	78,029	52,301	178,144		181,057	161,262	229,771	178,144	271,585	241,894	270,943	230,445	362,114	322,525	312,114	282,745
Other Operating Activities																					431
Other noncurrent assets																				34,219				(5,254)	5,760
Net Cash Used in Operating Activities, continued operations	(319,687)	(535,635)	(1,059,972)	(103,600)	(124,876)	282,157	6,018	1,734	41,080	4,974	49,063	(183,601)	(1,595,607)	157,281	42,814	(134,538)	(1,915,294)	53,681	48,832	(129,564)	(2,447,717)	(777,244)	(18,431)	(233,181)	280,088
Investing Activities
Plantation developments costs
Proceeds from sale of property and equipment		(1,255,382)
Pre-acquisition costs and deposit on refinery acquisition	(1,606,099)												(1,255,382)				(2,861,481)				(5,836,441)
Cash received from derivative forward contract
Net Cash Used in Investing Activities, continued operations	(1,606,099)	(1,255,382)											(1,255,382)				(2,861,481)				(5,836,441)
Financing Activities
Proceeds received from derivative forward contract																					4,000,000	6,000,000
Proceeds received from exercise of stock options	17,500																17,500				15,000
Debt issuance costs	(150,000)	(100,000)											(100,000)				(250,000)				(500,000)
Net Cash Provided by Financing Activities, continued operations	132,500	(100,000)											(100,000)				(232,500)				3,515,000	6,000,000
Cash Flows of discontinued operations:
Operating cash flows											64,257	153,758				218,015				218,015				220,641	(1,910,841)
Investing cash flows																									6,416,913
Financing cash flows (including cash at year end)																									(4,907,060)
Net Cash flows from discontinued operations											64,257	153,758				218,015				218,015				220,641	(400,988)
Effect of exchange rate changes on cash											(103,371)	(2,605)				(105,976)				(105,976)					(35,940)
Net change in Cash and Cash Equivalents	(2,058,286)	(1,891,017)	(1,059,972)	(103,599)	(124,876)	282,157	6,018	1,734	41,080	4,974	9,949	(32,448)	(2,950,989)	157,281	42,814	(22,499)	(5,009,275)	53,681	48,832	(17,525)	(4,769,158)	5,222,756	(18,431)	(12,540)	(156,840)
Cash and Cash Equivalents at Beginning of Period	2,275,500	4,166,517	5,226,489	161,014	285,890	3,733	64,978	63,244	22,164	12,205	2,256	34,704	5,226,489	3,733	22,164	34,704	5,226,489	3,733	22,164	34,704	5,226,489	3,733	22,164	34,704	191,544
Cash and Cash Equivalents at End of Period	$ 217,214	$ 2,275,500	$ 4,166,517	$ 57,415	$ 161,014	$ 285,890	$ 70,996	$ 64,978	$ 63,244	$ 17,179	$ 12,205	$ 2,256	$ 2,275,500	$ 161,014	$ 64,978	$ 12,205	$ 217,214	$ 57,415	$ 70,996	$ 17,179	$ 457,331	$ 5,226,489	$ 3,733	$ 22,164	$ 34,704